Document:

krclicenseagmt

        THIS LICENSE AGREEMENT is made as of the 15th day of February, 2002 between
The KRC Group, Inc., a corporation organized and existing under the laws of the
State of Delaware ("Licensor"), and InnerSpace Corporation, a corporation
organized and existing under the laws of the State of Delaware ("Licensee").

        The Effective Date is February 15, 2002.

        WHEREAS Licensor owns the Licensed Program and Licensed Technical
Information (each as defined below) and copyrights and other proprietary rights
relating thereto; and

        WHEREAS Licensee desires to obtain from Licensor, and Licensor desires to
grant to Licensee (i) an exclusive license to use the Licensed Program and
Licensed Technical Information in the State of Hawaii, subject to the terms,
conditions and provisions hereinafter set forth, and a (ii) nonexclusive license
to use the Licensed Program and Licensed Technical Information elsewhere,
subject to the terms, conditions and provisions hereinafter set forth;

        NOW, THERFORE in consideration of the premises and of the promises and
mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, and intending to be
legally bound hereby, the parties hereto agree as follows:

                                    ARTICLE 1
                                   DEFINITIONS

        The following terms, as used herein, shall have the following meanings:

        "AFFILIATE" means, when used with references to Licensee, any Person
directly or indirectly controlling, controlled by or under common control with
Licensee. For purposes of this Agreement, 'control' means the direct or indirect
ownership of over 50% of the outstanding voting securities of a Person, or the
right to receive over 50% of the profits or earnings of a Person, or the right
to control the policy decisions of a Person.

        "CONFIDENTIAL INFORMATION" means and includes (i) the source code and
object code of the Licensed Program and the related Documentation, (ii) the
Licensed Technical Information; and (iii) any other written or oral information
from which the furnishing party derives economic value, actual or potential,
from such information not being generally known to, and not being readily
ascertainable by proper means by, other persons who can obtain economic value
from its disclosure or use, and which is the subject of efforts that are
reasonable under the circumstances to maintain its secrecy.

        "COPYRIGHT" means the copyrights related to the Licensed Work, including
the copyright applications and registration(s), if any, listed on Exhibit A
attached hereto and made part hereof, authorized under Title 17 of the United
States Code or under the laws of any other jurisdiction.

                                       1

        "CUSTOMER" means any Person who has executed a valid End User Agreement or
any other form of sublicense agreement relating to the license set forth herein.

        "DOCUMENTATION" means the explanatory and instructive materials in
hardcopy, including manuals and other printed or visually perceptible materials
that describe the use, function or operation of a computer software program.

        "END USER AGREEMENT" means an agreement between Licensee and a Person
granting the right to use or benefit from any of the rights granted hereinunder.

        "LICENSE FEES" shall mean gross consideration actually received by Licensee
as a fee for use of the Licensed Work under the terms of any sublicense
agreement or for royalties. Licensor hereby acknowledges that Licensee has in
the past and will continue to provide consulting and other product related
services to third parties which do not employ the use of the Licensed Work, and
Licensor further acknowledges that such revenues are expressly not a part of
Licensee Fees as defined herein.

        "LICENSED PROGRAM" means the software program in source code, object code,
or any other form having the copyright registrations and applications for
copyright registration set forth in Exhibit A hereto and the specifications and
functionality described in Exhibit B hereto, together with (i) Modifications
thereto, (ii) all Documentation, and (iii) all derivative works based on the
foregoing.

        "LICENSED TECHNICAL INFORMATION" means data furnished by Licensor that is
used to populate the database component of the Licensed Program.

        "LICENSED WORK" means the Licensed Program, the Licensed Technical
Information and any derivative works, as well as all United States and foreign
Copyrights.

        "MODIFICATION" of work means any and all changes including improvements,
enhancements, corrections, revisions to the work or any portion thereof, and any
derivative of or work substantially similar to any of the foregoing, made by
Licensor or the Licensee.

        "PERSON" or "PERSONS" means any corporation, partnership, joint venture or
natural person.

        "PROVIDER" means a natural person, licensed as a physician, a nurse
practitioner or other medical professional, that provides healthcare services to
patients on a regularly scheduled basis and bills those patients for his or her
professional services. For purposes hereof, the term, "Provider" does not mean a
nurse or other allied health professional who assists the Provider in the
delivery of healthcare services to patients but who does not bill those patients
for his or her professional services.

        "SALE" as applied to the Licensed Work means a genuine bonafide transaction
for which consideration is received or expected for the use, lease, transfer or
any other disposition of the Licensed Work. A Sale of the Licensed Work shall be

                                       2

deemed completed at the time Licensee or its sublicensee receives payment for
such Licensed Work.

                                    ARTICLE 2
                                GRANT OF LICENSE

2.1 GRANT OF LICENSE. Subject to the terms and conditions contained in this
    Agreement, Licensor hereby grants to Licensee for the term of this
    Agreement a royalty-bearing, worldwide, nonexclusive license and a
    royalty-bearing, exclusive license for the State of Hawaii, with a right to
    sublicense to:

        (a) Host and use the Licensed Work;

        (b) make copies of, and make derivative works of, the Licensed Work, for
            the use of Licensee in accordance with the terms of this Agreement
            including, without limitation, the confidentiality provisions
            contained herein;

        (c) distribute the Licensed Work in object code only;

        (d) sublicense the Licensed Work in object code only to customers of
            Licensee who have first executed an End User Agreement in a form that
            is reasonably acceptable to Licensor;

        (e) market the Licensed Work on a private label basis.

2.2 RESERVATION OF RIGHTS. Licensor reserves the right to make copies of, to
    make derivative works of and to use the Licensed Work for commercial
    purposes and to license the Licensed Work to third parties subject to the
    terms of this Agreement.

2.3 NO RIGHTS BY IMPLICATION. No rights or licenses with respect to the
    Licensee Work are granted or deemed granted hereunder or in connection
    herewith, other than those rights or licenses expressly granted in this
    Agreement.

                                    ARTICLE 3
                                    ROYALTIES

3.1 ROYALTIES. In consideration for the license granted by this Agreement,
    royalties shall be payable as follows:

        (a) When Licensee has entered into End User Agreements with fewer than
            1,000 licensed Providers, Licensee shall pay Licensor:

                (i)  $66.38 per month per Provider for the first twelve (12) months
                     during which the Provider has access to the Licensed Work, and

                (ii) $33.19 per month per Provider for each succeeding month (after
                     expiration of the first twelve (12) months) during which the
                     Provider has access to the Licensed Work until the Provider
                     ceases to have access to the Licensed Work.

                                       3

(b) When Licensee has entered into End User Agreements with more than 1,000 but
    less than 1,500 licensed Providers, Licensee shall pay Licensor:

        (i) $51.63 per month per Provider for the first twelve (12) months during
            which the Provider has access to the Licensed Work, and

        (ii)$25.81 per month per Provider for each succeeding month (after
            expiration of the first twelve (12) months) during which the
            Provider has access to the Licensed Work until the Provider
            ceases to have access to the Licensed Work.

(c) When Licensee has entered into End User Agreements with more than 1,500
    licensed Providers, Licensee shall pay Licensor:

        (i) $36.88 per month per Provider for the first twelve (12) months during
            which the Provider has access to the Licensed Work, and

        (ii) $18.44 per month per Provider for each succeeding month (after
             expiration of the first twelve (12) months) during which the Provider
             has access to the Licensed Work until the Provider ceases to have
             access to the Licensed Work.

3.2 PAYMENTS. Royalties payable under Section 3.1 hereof shall be paid within
    thirty (30) days following the last day of the calendar month in which the
    royalties accrue. The final payment shall be made within thirty (30) days after
    termination of this Agreement. Royalties shall be deemed paid as of the day on
    which they are received at the account designated pursuant to Section 3.4. Fees
    for custom programming and professional services shall be paid within thirty
    (30) days following the receipt of invoice.

3.3 REPORTS. Licensee shall deliver to Licensor within forty-five (45) days
    after the end of each calendar month a report, certified by the chief financial
    officer of Licensee, setting forth in reasonable detail the calculation of the
    earned royalties available for credit payable to Licensor for such calendar
    month.

3.4 CURRENCY, PLACE OF PAYMENT. All dollar amounts referred to in this Agreement
    are expressed in United States dollars. All payments of Royalties and other
    amounts to Licensor under this Agreement shall be made in United States dollars
    by check payable to Licensor.

3.5 RECORDS. Licensee will maintain complete and accurate books and records
    which enable the royalties payable hereunder to be verified. The records for
    each calendar month shall be maintained for two (2) years after the submission
    of each report under Section 3.3 hereof. Upon reasonable prior notice to
    Licensee, Licensor and its accountant shall have access to the relevant books
    and records of Licensee necessary to conduct a review or audit thereof. Such
    limited access shall be available not more than twice each calendar year, during
    normal business hours, and for three years after the expiration or termination

                                       4

    of this Agreement. If Licensor determines that Licensee has under paid royalties
    by ten percent (10%) or more, Licensee will immediately pay to Licensor such
    amount plus interest at the rate of eighteen percent (18%) per annum in addition
    to the documented costs and expenses of Licensor's accountant in connection with
    its review or audit. If an overpayment is determined to exist, Licensor shall
    refund any monies overpaid by Licensee back to Licensee.

                                    ARTICLE 4
                                    WARRANTS

4.1 ISSUANCE. Licensee shall issue warrants in the form attached hereto as
    Exhibit "C" to the persons and in the amounts specified on Exhibit "C."

4.2 VESTING. Vesting of the warrants shall be subject to Licensor's completion
    of the tasks described in the vesting conditions attached hereto as Exhibit "D."

                                    ARTICLE 5
                               SOURCE CODE ESCROW

5.1 SOURCE CODE ESCROW. The parties shall enter into the Source Code Escrow
    Agreement attached hereto as Exhibit "E."

                                   ARTICLE 6
               HOSTING, TRAINING, SUPPORT AND MAINTENANCE SERVICES

6.1 HOSTING. Licensee and its agents will assume all responsibility for hosting
    the Licensed Work for the benefit of its Customers. Licensor will be under no
    obligation to host the Licensed Work for the benefit of Licensee or Licensee's
    Customers.

6.2 TRAINING AND IMPLEMENTATION. Licensor will provide remote technical
    assistance and consultation to Licensee with respect to use of the Licensed Work
    at a rate of the lesser of $800 per day or $150 per hour (billed in increments
    of 15 minutes).

6.3 MAINTENANCE. Licensor will correct defects and provide Licensee with fixes
    to the Licensed Work.. Any assistance required to fulfill Licensor's obligations
    under this Section will be provided at no additional charge unless such
    assistance is found to be the result of hardware failure, user error, neglect or
    negligence. Assistance required as a result of such failure, user error, neglect
    or negligence will be compensated by the Licensee at the rate of $150 per hour
    (billed in increments of 15 minutes).

6.4 UPGRADES. Licensor will support the Licensed Work to assure that it remains
    commercially viable and satisfies applicable regulatory and health industry
    standards. Licensor will provide Licensee with any and all upgrades it makes to
    the Licensed Work at no additional charge.

6.5 ACCESS TO LICENSED WORK. Licensee shall provide Licensor with remote access
    to the installed Licensed Work and its affiliated hardware during regular
    business hours, and for reasonable periods of time, for the purpose of testing,

                                       5

    identification of defects, and installation of any changes, fix or upgrade.
    Licensor will exercise best efforts to coordinate with Licensee an appropriate
    schedule to perform service and support so as to minimize the operational impact
    to Licensee's operations. In appropriate circumstances, at the sole discretion
    of Licensor, changes, fixes or upgrades may be delivered through appropriate
    magnetic media, electronically transmitted or delivered through a representative
    of Licensor.

6.6 TRAVEL. Should it be necessary to perform services described in this
    Agreement at HUI's site, Licensee shall be responsible for actual out-of-pocket
    expenses incurred for travel, meals and lodging that are preapproved by
    Licensee, and a per diem for those days during which services are actually
    performed. Service is defined as any act or attempt to install, deliver, change,
    repair, adjust, update, train or any other act requiring a credentialed
    technician. All administrative access, adjustments and setups are part of the
    unique features of the Licensed Work and are within the allowable functions of
    the Licensee's system administrator. It is expected that Licensee's system
    administrator will receive all Licensor provided application training. Support
    services will only be provided to designated individuals that have received
    application training from Licensor.

6.7 RESPONSE TIME. Licensor guarantees a best efforts attempt regarding the
    response time to a service call from the Licensee. Licensor will respond to
    service calls in the order received and will make every effort to respond within
    the timeframes specified in Exhibit "F" -- Software Maintenance Support Policy.

6.8 EXCUSED PERFORMANCE. Licensor shall not be liable for any failure to perform
    or delayed performance of any obligation under the Agreement if such performance
    is prevented, hindered or delayed by reason of any cause beyond the reasonable
    control of Licensor, including, without limitation, any labor dispute, strike or
    other industrial disturbance, act of God, flood, shortage of materials from
    various manufacturers, earthquakes, hurricanes, casualty, war, act of public
    enemy, riot, insurrection, embargo law, blockage, action, restriction and
    regulation or order of any government, government agency or subdivision thereof.

6.9 WARRANTY. Licensor warrants that the Licensed Work will operate in
    accordance with the performance specifications delineated at Exhibit B. Licensor
    will provide the services described in Article 6 and replace any defective
    Licensed Work in a prompt and professional manner, THIS WARRANTY IS IN LIEU OF
    ANY OTHER WARRANTIES, WHETHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT
    LIMITATION, IMPLIED WARRANTY OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
    PURPOSE. IN THE EVENT OF ANY BREACH OF THE WARRANTY CONTAINED IN THIS SECTION,
    LICENSOR'S SOLE RESPONSIBILITY SHALL BE TO PERFORM WHATEVER SERVICES ARE
    NECESSARY TO CORRECT PROBLEMS WITH ANY LICENSED PROGRAM SO THAT IT CONFORMS IN
    ACCORDANCE WITH ITS PUBLISHED SPECIFICATIONS.

                                       6

                                    ARTICLE 7
                         MODIFICATION OF LICENSED WORK.

7.1 MODIFICATIONS.

        (a) Based upon feedback from customers and other factors, Licensor shall
            (i) add new features and functions to the Licensed Program through new
            releases to the Licensed Program that Licensor issues to Licensee not
            less than biannually, and (ii) provide License will reasonable advance
            notice of pending releases and proposed release dates. Licensor will
            provide one copy of such new releases to Licensee without charge.

        (b) Licensee shall not have the right to make Modifications to the source
            code of the Licensed Program, unless Licensor fails to provide new
            releases to the Licensed Program as provided in Section 7.1(a) above.

        (c) Licensor shall be obligated to make Modifications requested by
            Licensee on a custom basis at the rate of $150 per hour (billed in 15
            minute increments) and on such other terms and conditions as the
            parties agree upon; provided, however, that Licensor shall not charge
            Licensee for Modifications it undertakes as a result of a request by
            Licensee if Licensor includes those Modifications in a new release
            Licensor issues in accordance with Section 7.1(a).

                                    ARTICLE 8
                                 CONFIDENTIALITY

8.1 NONDISCLOSURE.

        (a) Licensee shall maintain in confidence and shall not disclose to any
            third Party (except an authorized sublicensee) the Confidential
            Information received pursuant to this Agreement, without the prior
            written consent of Licensor. The foregoing obligation shall not apply
            to: (i) information that is known to Licensee or independently
            developed by Licensee prior to the time of disclosure; (ii)
            information disclosed to Licensee by a third party that has a right to
            make such disclosure; (iii) information that becomes patented,
            published or otherwise part of the public domain as a result of acts
            by Licensor or by a third person who has the right to make such
            disclosure; or (iv) information that is required to be disclosed by
            order of any governmental authority or a court of competent
            jurisdiction; provided that Licensee shall notify Licensor if it
            believes such disclosure is required and shall use its best efforts to
            obtain confidential treatment of such information by the agency or
            court.

        (b) Licensor shall maintain in confidence and shall not disclose to any
            third Party (except an authorized sublicensee) the Confidential
            Information received pursuant to this Agreement, without the prior
            written consent of Licensee. The foregoing obligation shall not apply
            to: (i) information that is known to Licensor or independently
            developed by Licensor prior to the time of disclosure; (ii)

                                       7

            information disclosed to Licensor by a third party that has a right to
            make such disclosure; (iii) information that becomes patented,
            published or otherwise part of the public domain as a result of acts
            by Licensee or by a third person who has the right to make such
            disclosure; or (iv) information that is required to be disclosed by
            order of any governmental authority or a court of competent
            jurisdiction; provided that Licensor shall notify Licensee if it
            believes such disclosure is required and shall use its best efforts to
            obtain confidential treatment of such information by the agency or
            court.

        (c) The receiving party's obligations of confidentiality with respect to
            Confidential Information that constitute trade secrets under the
            Uniform Trade Secrets Act as adopted in the State of Georgia (or other
            similar applicable law) shall run for as long as such information
            remains a trade secret. The receiving party's obligations of
            confidentiality with respect to Confidential Information that is not
            covered under the Uniform Trade Secrets Act as adopted in the State of
            Georgia (or other similar applicable law), shall run for three (3)
            years from the date of termination of this Agreement.

8.2 USE OF CONFIDENTIAL INFORMATION.

        (a) Licensee shall ensure that all of its employees, agents and
            contractors having access to the Confidential Information of Licensor
            are obligated in writing to abide by Licensee's obligations hereunder.
            Licensee shall use the Confidential Information only for the purposes
            contemplated under this Agreement.

        (b) Licensor shall ensure that all of its employees, agents and
            contractors having access to the Confidential Information of Licensee
            are obligated in writing to abide by Licensor's obligations hereunder.
            Licensor shall use the Confidential Information only for the purposes
            contemplated under this Agreement.

8.3 INJUNCTIVE RELIEF. Because damages at law will be an inadequate remedy for
    breach of any of the covenants, promises and agreements contained in this
    Article 6 hereof, the aggrieved party shall be entitled to injunctive
    relief in any state or federal court located within the City of Atlanta,
    Georgia, including specific performance or an order enjoining the breaching
    party from any threatened or actual breach of such covenants, promises or
    agreements. The rights set forth in this Section shall be in addition to
    any other rights which the aggrieved party may have at law or in equity.

                                    ARTICLE 9
                         WARRANTIES AND REPRESENTATIONS

9.1 REPRESENTATIONS AND WARRANTIES OF LICENSOR. Licensor represents and warrants
    to Licensee that

        (a) Licensor is a corporation duly organized, validly existing and in good
            standing under the laws of Delaware, and has all requisite corporate
            power and authority to execute, deliver and perform this Agreement.

                                       8

        (b) This Agreement, when executed and delivered by Licensor, will be the
            legal, valid and binding obligation of Licensor, enforceable against
            Licensor in accordance with its terms.

        (c) The execution, delivery and performance of this Agreement by Licensor
            does not conflict with, or constitute a breach or default under, (i)
            the charter documents of Licensor, (ii) any law, order, judgment or
            governmental rule or regulation applicable to Licensor, or (iii) any
            provision of any agreement, contract, commitment or instrument to
            which Licensor is a party; and the execution, delivery and performance
            of this Agreement by Licensor does not require the consent, approval
            or authorization of, or notice or declaration to or filing or
            registration with, any governmental or regulatory authority.

        (d) Licensor holds full right, title and interest in and to the Licensed
            Work. To its knowledge, the Licensed Work does not infringe the
            proprietary rights of any third party. Licensor has not received any
            written notice that the Licensed Work infringes the proprietary rights
            of any third party.

9.2 REPRESENTATIONS AND WARRANTIES OF LICENSEE. Licensee represents and warrants
    to Licensor that

        (a) Licensee is a corporation duly organized, validly existing and in
            good standing under the laws of Delaware, and has all requisite
            corporate power and authority to execute, deliver and perform
            this Agreement.

        (b) This Agreement, when executed and delivered by Licensee, will be
            the legal, valid and binding obligation of Licensee, enforceable
            against Licensee in accordance with its terms.

        (c) The execution, delivery and performance of this Agreement by
            Licensee does not conflict with, or constitute a breach or
            default under, (i) the charter documents of Licensee, (ii) any
            law, order, judgment or governmental rule or regulation
            applicable to Licensee, or (iii) any provision of any agreement,
            contract, commitment or instrument to which Licensee is a party;
            and the execution, delivery and performance of this Agreement by
            Licensee does not require the consent, approval or authorization
            of, or notice or declaration to or filing or registration with,
            any governmental or regulatory authority.

                                   ARTICLE 10
                       PROPRIERARY RIGHTS AND INFRINGEMENT

10.1 RIGHTS PROTECTION.

        (a) LICENSOR CONTROL. Licensor shall be responsible for and shall
            control the preparation, prosecution and maintenance of all
            copyrights and patent rights pertaining to the Licensed Work.

                                       9

        (b) LICENSEE PROSECUTION. If Licensor elects not file, prosecute or
            maintain any copyright or patent to the Licensed Work, it shall
            notify Licensee at least sixty (60) days prior to taking, or not
            taking, any action which would result in abandonment, withdrawal,
            or lapse of such right. Licensee shall then have the right to
            file, prosecute or maintain the right at its own expense and set
            off such expense from the royalty payments due Licensor
            hereinunder.

        (c) COOPERATION. Each party shall cooperate with the other party to
            execute all lawful papers and instruments and to make all
            rightful oaths and declarations as may be necessary in the
            preparation and prosecution of all rights referred to in this
            Section.

10.2 OWNERSHIP. Licensee acknowledges that all right, title an interest in and
     to the Licensed Work and any copyrights, patents, and other protection
     related thereto is and shall remain in Licensor, regardless of which party
     prepares prosecutes or maintains the foregoing, subject to the express
     license granted to Licensee under Article 2 hereof.

10.3 INTELLECTUAL PROPERTY INFRINGEMENT CLAIMS; INFRINGEMENT BY THIRD PARTY.

        (a) INFRINGEMENT CLAIMS. Licensor shall hold and save Licensee harmless
            from, and shall pay, when due, any loss, damage or liability,
            including reasonable attorneys' fees and expenses, awarded against or
            incurred by Licensee for or account of any charge, claim, suit or
            proceeding that alleges or is based upon a claim that the License
            Program, or any portion thereof, infringes any intellectual property
            rights of any third party. If any part of the Licensed Program becomes
            the subject of a claim of infringement hereunder, Licensee, at its
            option, may either (1) secure the right to continue using that part of
            the License Program, or (ii) replace or modify that part of the
            Licensed Program to make the Licensed Program noninfringing. In this
            event, Licensee shall have the right to set off the costs thereof
            against the royalty payments due Licensor hereinunder.

        (b) THIRD PARTY INFRINGEMENT.

                (i) LICENSEE'S OBLIGATIONS. Each party will promptly notify the other
                    party of any infringement or possible infringement of rights
                    relating to the Licensed Work by a third-party. Licensee shall
                    have the right, but not the obligation, to prosecute such
                    infringement at its own expense. In such event, Licensor shall
                    cooperate with Licensee, at Licensee's expense. Licensee shall
                    not settle or compromise any such suit in a manner that imposes
                    any obligations or restrictions on Licensor or grants any rights
                    to the Licensed Work, without Licensor's written consent.

                (ii)LICENSOR'S RIGHTS. If Licensee fails to prosecute such
                    infringement within ninety (90) days after receiving notice
                    thereof, Licensor shall have the right, but not the obligation,
                    to prosecute such infringement at its own expense. In such event,

                                       10

                    Licensee shall cooperate with Licensor, at Licensor's expense.

               (iii)RECOVERY DISTRIBUTION. Any recovery obtained by the prosecuting
                    party as a result of such proceeding, by settlement or otherwise,
                    shall be applied first to the prosecuting party, in an amount
                    equal to its costs and expenses of the litigation, with the
                    remainder to be paid to the Licensee, subject to the earned
                    royalties due to Licensor under Article 3 hereof.

                                   ARTICLE 11
                              TERM AND TERMINATION

11.1 TERM. This Agreement and the licenses granted herein shall commence on the
     Effective Date and shall continue, subject to earlier termination under
     Sections 11.2 or 11.3 hereof, in perpetuity or, if a specified term is
     required by law, for a period of thirty (30) years thereafter.

11.2 TERMINATION BY LICENSOR.

        (a) EVENTS OF DEFAULT. Upon the occurrence of any of the events set forth
            below ("Events of Default"), Licensor shall have the right to
            terminate this Agreement by giving written notice of termination, such
            termination being effective with the giving of such notice:

                (i) Nonpayment of any amount payable to Licensor that is continuing
                    then (10) calendar days after Licensor gives Licensee written
                    notice of such nonpayment;

                (ii) breach by Licensee of any covenant (other than a payment breach
                     referred to in clause (i) above) or any representation or
                     warranty contained in this Agreement that is continuing sixty
                     (60) calendar days after Licensor gives Licensee written notice
                     of such breach; provided that if Licensee, using its best
                     efforts, cannot cure such breach within the flat sixty (60) days,
                     the cure period shall be extended by an additional sixty (60)
                     calendar days, the total cure period not to exceed one hundred
                     twenty (120) days; or

               (iii)Licensee fails to comply with the terms of the license granted
                    under Article 2 hereof and such noncompliance is continuing
                    thirty (30) calendar days after Licensor gives Licensee notice of
                    such noncompliance;

11.3 NO WAIVER. No exercise by Licensor of any right of termination shall
     constitute a waiver of any right of Licensor for recovery of any monies
     then due to it hereunder or any other right or remedy Licensor may have at
     law or under this Agreement.

11.4 RIGHTS AND DUTIES UPON TERMINATION. Within thirty (30) days after
     termination of this Agreement, each party shall return to the other party
     any Confidential Information of the other Party. Licensee also shall return

                                       11

     all copies of the Licensed Program in its possession that are embodied in
     physical form to Licensor promptly upon the termination of this Agreement.

11.5 SUBLICENSES. Any sublicenses granted by Licensee under this Agreement and
     conforming substantially to the form of End User License Agreement agreed
     to by the parties shall survive termination of this Agreement in accordance
     with the terms of such sublicense.

11.6 PROVISIONS SURVIVING TERMINATION. Licensee's obligation to pay Royalties
     accrued but unpaid prior to termination of this Agreement shall survive
     such termination. In addition, any other provisions required to interpret
     the rights and obligations of the parties arising prior to the termination
     date shall survive expiration or termination of this Agreement.

                                   ARTICLE 12
                              ADDITIONAL PROVISIONS

12.1 ASSIGNMENT. This Agreement may be assigned by either party upon written
     notice to the nonassigning party. Any such purported assignment, without
     the written consent of Licensor, shall be null and of no effect. No
     assignment shall relieve Licensee of responsibility for the performance of
     any obligations which have accrued prior to such assignment.

12.2 NO WAIVER. A waiver by either party of a breach or violation of any
     provision of this Agreement must be in writing in order to be effective. No
     waiver will constitute or be construed as a waiver of any subsequent breach
     or violation of that provision or as a waiver of any breach or violation of
     any other provision of this Agreement.

12.3 INDEPENDENT CONTRACTOR. Nothing herein shall be deemed to establish a
     relationship of principal and agent between Licensor and Licensee, nor any
     of their agents or employees for any purpose whatsoever. This Agreement
     shall not be construed as constituting Licensor and Licensee as partners,
     or as creating any other form of legal association or arrangement that
     could impose liability upon one party for the act or failure to act of the
     other party.

12.4 NOTICES. Any notice under this Agreement shall be sufficiently given if
     sent in writing by prepaid, first class, certified or registered mail,
     return receipt requested, addressed as follows:

        (a) If to Licensor, to

                  The KRC Group, Inc.
                  3654 Canton Road
                  Suite 103
                  Marietta, GA 30066-2619

                                       12

        (b) If to Licensee, to:

                  InnerSpace Corporation
                  201 Allen Road NE
                  Suite 310
                  Atlanta, Georgia  30328-4864

                  or to such other addresses as may be designated from time to time
                  by notice given in accordance with the terms of this Section.

12.5 ENTIRE AGREEMENT. This Agreement embodies the entire understanding between
     the parties relating to the subject matter hereof and supersedes all prior
     understandings and agreements, whether written or oral. This Agreement may
     not be varied except by a written document signed by duly authorized
     representatives of both parties.

12.6 SEVERABILITY. Any of the provisions of this Agreement which are determined
     to be invalid or unenforceable in any jurisdiction shall be ineffective to
     the extent of such invalidity or unenforceability in such jurisdiction,
     without rendering invalid or unenforceable the remaining provisions hereof
     or affecting the validity or unenforceability of any of the terms of this
     Agreement in any other jurisdiction.

12.7 HEADINGS. Any headings and captions used in this Agreement are for
     convenience of reference only and shall not affect its construction or
     interpretation.

12.8 NO THIRD PARTY BENEFITS. Nothing in this Agreement, express or implied, is
     intended to confer on any person other than the parties hereto or their
     permitted assigns, any benefits, rights or remedies.

12.9 GOVERNING LAW. This Agreement shall be construed, governed, interpreted and
     applied in accordance with the laws of the State of Georgia, without giving
     effect to conflict of law provisions.

12.10 COUNTERPARTS. This Agreement shall become binding when any one or more
      counterparts hereof, individually or taken together, shall bear the
      signatures of each of the parties hereto. This Agreement may be executed in
      any number of counterparts, each of which shall be deemed an original as
      against the party whose signature appears thereon, but all of which
      together shall constitute but one and the same instrument.

12.11 FURTHER ASSURANCES. The parties shall sign such other instruments, cause
      such meetings to be held and resolutions passed, exercise their vote and
      influence, do and perform and cause to be done and performed such further
      and other acts as things as may be reasonably necessary or desirable to
      give full effect to the intent and purposes of this Agreement.

                                       13

IN WITNESS WHEREOF AND INTENDING TO BE BOUND, the parties hereto execute this
Agreement through their authorized representatives as of the date first above
written.

INNERSPACE CORPORATION

By:/s/Robert D. Arkin
   Robert D. Arkin
   Chief Executive Officer

THE KRC GROUP, INC.

By:/s/Robert Crowe
   Robert Crowe
   Chief Executive Officer

                                       14

                                    EXHIBIT A
                             COPYRIGHT REGISTRATIONS

None.

                                       15

                                    EXHIBIT B
                     LICENSED PROGRAM PRODUCT SPECIFICATIONS

MAXeMD(TM)is a web based clinical application. Its intent is to provide
physicians and their clinical staff and office staff with a documentation tool
that will replace the hand written chart and encounter notes. MAXeMD(TM)
includes all aspects of the current paper chart and has all the benefits of
online accessibility of patient data. Features and functionality are as follows:

     Chart                              Description                                  Data

Demographic Information       This is the demographic profile for the      First Middle and Last Name
                              patient chart.                               Address, City State Zip
                                                                           4 phone number w/phone type
                                                                           Alert-Comments
                                                                           Employer Information
                                                                           Worker's Compensation check box
                                                                           Emergency contacts
                                                                           Physician List
                                                                           Insurance List

Patient Search                The ability to search the database for the   By Name (First or Last)
                              correct patient chart.                       Social Security
                                                                           Account Number

Medical History Record        This is the documentation of historical      Medical History
                              medical data.                                Surgical History
                                                                           Family History
                                                                           Social History
                                                                           Advance Directives

Worklist                      This is a dynamic worklist that changes      Patient name appears on nurse/tech worklist based on check in
                              based on workflow of the office.             Patient name appears on physician worklist based on completed
                                                                           initial workup
                                                                           Patient name appears on nurse/tech worklist based on diagnostic
                                                                           work
                                                                           Patient name appears on physician worklist based on diagnostic
                                                                           work up completed
                                                                           Patient name appears on front office staff worklist based on
                                                                           encounter E&M Coding completed

Medication Record             This is a list of medications that can be    Medication List
                              viewed by ALL, Current, and Discontinued     Medication Name
                              meds.  There is the ability to add, edit,    Dose / Route/ Freq
                              and print a prescription.   There is the     Start & Stop Date
                              ability to document each Rx refill by date   Rx Printing
                              and user authorizing the refill.             Rx Renewal

                                       16

Problem List                  This is the list of all patient's            Date
                              problems.  The user has the ability to add   Problem Description
                              a problem, resolve a problem and update      Diagnosis code associated with the problem
                              the status of the problem.                   Problem Status (Acute, Chronic, Stable etc.)

Office Notes                  This is a chronological list of office       Date
                              notes. These notes can be anything from      Patient Specific Problem Associated
                              interoffice communications; Rx refill        Contact Type
                              request; request to diagnostic result        Note text
                              reporting to patient; external office        Next contact date for follow-up
                              letters regarding patient care.  There is    Next contact type
                              also the ability to add a contact to the     Next Contact subject
                              worklist as to streamline follow up
                              issues.

Diagnostic Studies            This is a chronological list of diagnostic   Date
                              studies ordered during an encounter.         Description
                                                                           Results (if entered or available via interface - interface is not
                                                                           part of basic product)

Immunization Record           This is a chronological list of              Date
                              immunizations ordered during an encounter    Consent signed verification
                              or added based on historical patient's       Immunization description
                              statements or referral data.                 Immunization administration information (manufacture, lot #,
                                                                           serial #, expiration date, dose, route, serology information)
                                                                           # of doses for serial immunization

Patient Education Record      This is the documentation of all patient     Education Record- documents the instruction given to patient
                              education instructions and material given    Education Material- documents distribution of education material
                              to the patient during the encounter.

Procedure List with           This is a chronological list of procedures   Date
Documentation                 ordered and performed during an encounter    Description of Procedure (CPT coded)
                              or added based on historical patient's       Default statements for each procedure for patient specific
                              statements or referral data.                 editing.

Referral List                 This is a chronological list of referrals    Date
                              ordered during an encounter or added based   Referral description
                              on historical patient's statements or        Referral information (to whom, contact information, comment text)
                              referral data.                               Referral completion

                                       17

ER/Hospital Encounter         This is a chronological list of encounters   Admission/Visit Date
Tracking                      that the patient has experienced.            Discharge Date
                                                                           Encounter description
                                                                           Admission/Visit reason
                                                                           Admission/Visit physician

Order Profile                 This is a summary screen of all orders       Date
                              that have been placed during all             Order by category
                              encounters.  The orders can be viewed by     Order Status
                              ALL, Active orders, Completed Orders         Order results or documentation

Super Bill Tracking           This is a summary screen of all encounters   List of encounters
                              with specific links to the date specific     Dates (link to encounter details)
                              super bill.                                  Encounter Description
                                                                           Encounter E&M Code

Encounter Documentation                  Description                                Data

Patient Check in              This is the screen that the front office     Front office check in
                              staff uses to notify the clinical office     Encounter Date
                              staff that the patient is ready to be seen   Clinic Site
                              by the clinical staff.                       Clinic Account #
                                                                           Clinic Chart #
                                                                           Encounter Physician
                                                                           Patient account status

Chief Complaint               This is the screen where the clinical        Practice Specific Chief Complaints
                              staff documents the reason for visit.  The   Patient Comment text for patient quotes
                              description checked here drives the data     Description check boxes
                              presented in the HPI and the list of
                              diagnosis presented in the Clinical
                              Impression screen and the Final Diagnosis
                              screen.

Initial Workup                This is the screen where the initial         Date
                              clinical data that is collected on intake    Display of chief complaint (s)
                              is documented.                               Height
                                                                           Weight
                                                                           Temperature
                                                                           Pulse

                                       18

                                                                           Respiration
                                                                           BP (2)
                                                                           BP location
                                                                           BP body position
                                                                           LMP for female patients
                                                                           Vision Screening (w or w/o glasses check boxes)

History of Present Illness    This is the screen that allows detailed      Detail description check boxes based on the checked chief
                              documentation of adjective and supportive    complaints as to:
                              data in regards to the chief complaint.               Context
                                                                                    Quality
                                                                                    Severity
                                                                                    Location
                                                                                    Duration
                                                                                    Timing
                                                                                    Modifying Factors
                                                                                    Signs and Symptoms
                                                                           Free texts field for each of the above

Pertinent Medical History     This is the screen where the clinician       Display of documented history by category
                              checks any pertinent medical history that    Links to the documentation screens to add history if needed.
                              applies to the current encounter and
                              should be considered in making a diagnosis
                              for he current encounter.

Review of System              This is a list of categories that the        Documentation options:  Not reviewed, Negative, or Positive.
                              clinician reviews with the patient that      Categories are configurable - but current ones in system are as
                              may be pertinent to making a diagnosis       follows:
                                                                                    General
                                                                                    Eyes
                                                                                    ENT
                                                                                    Cardiovascular
                                                                                    Respiratory
                                                                                    GI
                                                                                    GU
                                                                                    Musculoskeletal
                                                                                    Skin
                                                                                    Breast
                                                                                    Neurological
                                                                                    Psychiatric
                                                                                    Endocrine
                                                                                    Hematologic/Lymphatic
                                                                                    Allergic/Immunologic
                                                                           Positive findings by category with comment field
                                                                           Ability to order category display
                                                                           Ability to add, edit and delete the category description

                                       19

Physical Exam                 This is a list of categories that the        Documentation options:  Not Examined, Normal Statements, Abnormal
                              clinician examines on the patient that may   Statements by category specific statements.  Categories are
                              be pertinent to making a diagnosis.          configurable - but current ones in system are as follows:
                                                                                    General
                                                                                    Eyes
                                                                                    ENT
                                                                                    Face & Head
                                                                                    Cardiovascular
                                                                                    Lungs
                                                                                    Abdomen
                                                                                    Back
                                                                                    Neck
                                                                                    GU-Female
                                                                                    GU-Male
                                                                                    Musculoskeletal
                                                                                    Skin
                                                                                    Breast
                                                                                    Neurological
                                                                                    Psychological
                                                                           Abnormal findings by category with comment field
                                                                           Ability to order category display
                                                                           Ability to add, edit and delete the category description

Clinical Impression           This a list of potential diagnosis that is   List of ICD code and description based on chief complaint chosen.
                              displayed based on the chief complaint.      Add diagnosis) list of practice specific diagnosis by description
                              The diagnosis chosen here drives the         and code should the system not list the needed diagnosis
                              treatment plan displayed.

Final Diagnosis               This is a list of potential diagnosis that   List of ICD code and description based on chief complaint chosen.
                              is displayed based on the chief complaint-   Add diagnosis) list of practice specific diagnosis by description
                              and confirmed with diagnostics workup        and code should the system not list the needed diagnosis
                              performed in the clinic.  There is the       Selection of primary diagnosis
                              ability to select a primary diagnosis and    Add to problem list check box
                              to add the problem to the Problem List.
                              The diagnosis chosen here drives the
                              treatment plan displayed.

                                       20

Treatment Plan                This a treatment plan by category of plan    List of treatment plan by category based on Diagnosis selected.
                              based on the diagnosis selected in the       Category as follows:
                              clinical impression screen and/or the                 Medication- Rx
                              final diagnosis screen.                               In Office Medication
                                                                                    Diagnostic Test
                                                                                    Procedures
                                                                                    Immunizations
                                                                                    Referral
                                                                                    Patient Education
                                                                                    Follow-up

Order Profile                 This is a summary screen of all orders       Ability to update and document completion of orders
                              that have been placed during this                     Medication- Rx (Rx printed and given to patient)
                              encounter.  The orders can be viewed by               In Office Medication (Medication Administration Record -
                              ALL, Active orders, Completed Orders.                 MAR)
                              Each category of the order can be updated             Diagnostic Test- (In office lab result reporting)
                              and documented against based on category              Procedures- (defaulted documentation specific to the
                              specific data.                                        procedure - to be edited base on patient specifics)
                                                                                    Immunizations- (Immunization Administration Record)
                                                                                    Referral- (List of specific as to the referral)
                                                                                    Patient Education- (Instruction and Patient Education
                                                                                    Material)
                                                                                    Follow-up- (date and time- return to work / school
                                                                                    information)

E& M Coding                   This is the screen that displays             The ability to document E&M code for the encounter
                              information pertinent to making a            Based on
                              selection as to the encounter E&M Criteria.  New or Established
                                                                           Level I, II, III, or IV visit

Super Bill                    This is a summary screen of all orders,      Date
                              diagnosis, and the E&M Code for the          List of ordered items
                              encounter.                                   E&M code
                                                                           Diagnosis list with primary diagnosis identified.

Encounter Note                This is an encounter summary note that is    Encounter summary documentation includes:
                              chart ready if print is needed.                       Encounter date & location
                                                                                    Patient Header information

                                       21

                                                                                    Vitals sign data
                                                                                    Chief complaint statement with HPI narrative
                                                                                    Pertinent Medical History
                                                                                    ROS
                                                                                    EXAM
                                                                                    Final Diagnosis
                                                                                    Current Medication list
                                                                                    Orders by category with order status
                                                                                    Encounter physician

                                       22

                             INNERSPACE CORPORATION

                          COMMON STOCK PURCHASE WARRANT

                          DATED AS OF FEBRUARY 15, 2002

            CHRIS A. IVALIOTES AND MARY ANN IVALIOTES, JOINT TENANTS

                                       23

THIS WARRANT AND THE SHARES OF COMMON STOCK COVERED HEREBY (COLLECTIVELY, THE
"SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE GEORGIA SECURITIES ACT OF 1973,
AS AMENDED ("GEORGIA ACT"), IN RELIANCE UPON THE EXEMPTION PROVIDED BY SECTION
9(m) (NOW CODIFIED AS O.C.G.A. SECTION 10-5-9(13)) THEREOF, AND HAVE NOT BEEN
REGISTERED UNDER ANY OTHER STATE SECURITIES LAW OR THE SECURITIES ACT OF 1933,
AS AMENDED ("FEDERAL ACT"). THE SECURITIES WILL BE ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED, NOR WILL ANY
ASSIGNEE OR TRANSFEREE THEREOF BE RECOGNIZED BY INNERSPACE CORPORATION (THE
"COMPANY") AS HAVING ANY INTEREST IN SUCH SECURITIES, IN THE ABSENCE OF (i) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
GEORGIA ACT, OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL SHALL BE
SATISFACTORY TO THE COMPANY, THAT THE TRANSACTION BY WHICH SUCH SECURITIES WILL
BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED IS EXEMPT UNDER THE
GEORGIA ACT OR IS OTHERWISE IN COMPLIANCE WITH THE GEORGIA ACT; AND (ii) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
FEDERAL ACT, AND ANY OTHER APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF
COUNSEL, WHICH OPINION AND COUNSEL SHALL BE SATISFACTORY TO THE COMPANY, THAT
SUCH REGISTRATION IS NOT REQUIRED.

                             INNERSPACE CORPORATION
                          COMMON STOCK PURCHASE WARRANT

Warrant No. 1                                            No. of Shares - 20,000

        This certifies that, for value received, Chris A. Ivaliotes and Mary Ann
Ivaliotes, joint tenants with right of survivorship, hereinafter referred to
collectively as the registered holder, or its successors and assigns, is
entitled, subject to the terms and conditions hereinafter set forth, at or
before 5:00 o'clock P.M., Eastern time, on February 15, 2006, but not
thereafter, to purchase 20,000 shares of $.001 par value Common Stock (the
"Common Stock") of INNERSPACE CORPORATION, a Delaware corporation (the
"Company"), such number of shares being subject to adjustment upon the
occurrence of the contingencies set forth in this Warrant. The purchase price
payable upon the exercise of this Warrant shall be $1.00 per share, said amount
being hereinafter referred to as the "Warrant Price" and being subject to
adjustments upon the occurrence of the contingencies set forth in this Warrant.

        Upon delivery of this Warrant with the subscription form annexed hereto,
duly executed, together with payment of the Warrant Price for the shares of
Common Stock thereby purchased, at the principal office of the Company, 201
Allen Road NE, Suite 310, Atlanta, Georgia 30328-4864, or at such other address
as the Company may designate by notice in writing to the registered holder
hereof, the registered holder of this Warrant shall be entitled to receive a
certificate or certificates for the shares of Common Stock so purchased. All
shares of Common Stock which may be issued upon the exercise of this Warrant
will, upon issuance, be fully-paid and non-assessable and free from all taxes,
liens and charges with respect thereto.

        This Warrant is subject to the following terms and conditions:

                                       24

1.      Optional Exercise of Warrant. This Warrant may be exercised in whole at any
        time, or in any part from time to time, at or prior to 5:00 o'clock P.M.,
        Eastern time, on February 15, 2006, but not thereafter, as to all or any
        part of the number of whole shares of Common Stock then subject hereto.
        Payment of the Warrant Price shall be made in cash. In case of any partial
        exercise of this Warrant, the Company shall execute and deliver a new
        Warrant of like tenor and date for the balance of the shares of Common
        Stock purchasable hereunder. Upon any exercise of this Warrant, Optionee
        may, in lieu of payment of the Warrant Price in cash, surrender this
        Warrant (or any successor hereto or fraction hereof) (valued for such
        purpose at the Fair Market Value of the underlying Common Stock for which
        such Warrant is exercisable on the date of such exercise less the Warrant
        Price then in effect) and apply all or a portion of the amount so
        determined to the payment of the Warrant Price for the number of shares of
        Common Stock being purchased.

2.      Adjustment of Warrant Price and Number of Shares Purchasable Hereunder. In
        case the Company shall at any time subdivide the outstanding shares of its
        Common Stock, the Warrant Price in effect immediately prior to such
        subdivision shall be proportionately decreased, and in case the Company
        shall at any time combine the outstanding shares of its Common Stock, the
        Warrant Price in effect shall immediately prior to such combination be
        proportionately increased, effective from and after the record date of such
        subdivision or combination, as the case may be.

3.      Notice of Adjustments. Upon any adjustment of the Warrant Price and any
        increase or decrease in the number of shares of Common Stock purchasable
        upon the exercise of this Warrant, then and in each such case, the Company,
        within thirty (30) days thereafter, shall give written notice thereof to
        the registered holder of this Warrant at the address of such holder as
        shown on the books of the Company, which notice shall state the Warrant
        Price as adjusted and the increased or decreased number of shares
        purchasable upon the exercise of this Warrant, setting forth in reasonable
        detail the method of calculation of each. The holder of the Warrant shall
        have 10 days in which to review the proposed adjustment and to object to
        the proposed adjustment by notifying the Company in writing of such
        objection, setting forth in reasonable detail the reasons for such
        objection. If the holder fails to object to the proposed adjustment during
        such 10-day period the proposed adjustment shall become final. If the
        holder objects to the proposed adjustment then the Company and the holder
        shall attempt to reconcile their differences and if unable to do so such
        adjustment shall be determined by the Company's independent accountants
        whose determination shall be final.

4.      Notice of Exercise of Option. This Option may be exercised by the Optionee
        by a written notice signed by the Optionee, and delivered or mailed to the
        Company to the attention of the President. The notice shall specify the
        number of shares of Stock which the Optionee elects to purchase hereunder,
        and be accompanied by (i) a certified or cashier's check payable to the
        Company in payment of the total Exercise Price applicable to such shares as
        provided herein, (ii) shares of Stock owned by Optionee and duly endorsed
        or accompanied by stock transfer powers having a Fair Market Value equal to
        the total Exercise Price applicable to such shares purchased hereunder, or
        (iii) a certified or cashier's check accompanied by a certificate or

                                       25

        certificates representing the number of shares of Stock whose Fair Market
        Value when added to the amount of the check equals the total Exercise Price
        applicable to such shares purchased hereunder. Upon receipt of an such
        notice and accompanying payment, the Company agrees to issue to the
        Optionee stock certificates for the number of shares specified in such
        notice registered in the name of the Optionee.

5.      Charges, Taxes and Expenses. The issuance of certificates for shares of
        Common Stock upon any exercise of this Warrant shall be made without charge
        to the holder hereof for any tax or other expense in respect to the
        issuance of such certificates, all of which taxes and expenses shall be
        paid by the Company, and such certificates shall be issued in the name of,
        or in such name or names as may be directed by, the holder of this Warrant;
        provided, however, that in the event that certificates for shares of Common
        Stock are to be issued in a name other than the name of the holder of this
        Warrant, this Warrant when surrendered for exercise shall be accompanied by
        an instrument of transfer in form satisfactory to the Company, duly
        executed by the holder hereof in person or by an attorney duly authorized
        in writing.

6.      Certain Obligations of the Company. The Company will not, by amendment of
        its Certificate of Incorporation or through reorganization, consolidation,
        merger, dissolution or sale of assets, or by any other voluntary act or
        deed, avoid or seek to avoid the performance or observance of any of the
        covenants, stipulations or conditions to be performed or observed by the
        Company, but will at all times in good faith assist, insofar as it is able,
        in the carrying out of all provisions of this Warrant and in the taking of
        all other action which may be necessary in order to protect the rights of
        the holder of this Warrant against dilution. Without limiting the
        generality of the foregoing, the Company agrees that it will not establish
        or increase the par value of the shares of any Common Stock which are at
        the time issuable upon exercise of this Warrant above the then prevailing
        Warrant Price hereunder and that, before taking any action which would
        cause an adjustment reducing the Warrant Price hereunder below the then par
        value, if any, of the shares of any Common Stock issuable upon exercise
        hereof, the Company will take any corporate action which may, in the
        opinion of its counsel, be necessary in order that the Company may validly
        and legally issue fully-paid and non-assessable shares of such Common Stock
        at the Warrant Price as so adjusted.

7.      Miscellaneous.

        a.      The Company covenants that it will at all times reserve and keep
                available, solely for the purpose of issue upon the exercise hereof, a
                sufficient number of shares of Common Stock to permit the exercise
                hereof in full and a sufficient number of shares of Common Stock to
                permit the conversion of all such shares of Common Stock.

        b.      The terms of this Warrant shall be binding upon and shall inure to the
                benefit of any successors or assigns of the Company and of the holder
                or holders hereof and of the Common Stock issued or issuable on the
                exercise hereof.

                                       26

        c.      No holder of this Warrant, as such, shall be entitled under this
                Warrant to vote or receive dividends (except as provided in paragraph
                2 hereof) or be deemed to be a shareholder of the Company for any
                purpose.

        d.      This Warrant may be divided into separate Warrants covering one share
                of the Common Stock or any whole multiple thereof, for the total
                number of shares of Common Stock then subject to this Warrant at any
                time, or from time to time, upon the request of the registered holder
                of this Warrant and the surrender of the same to the Company for such
                purpose. Such subdivided Warrants shall be issued promptly by the
                Company following any such request and shall be of the same form and
                tenor as this Warrant, except for any requested change in the name of
                the registered holder stated herein.

        e.      Except as otherwise provided herein, this Warrant and all rights
                hereunder are transferable by the registered holder hereof in person
                or by duly authorized attorney on the books of the Company upon
                surrender of this Warrant, properly endorsed, to the Company. The
                Company may deem and treat the registered holder of this Warrant at
                any time as the absolute owner hereof for all purposes and shall not
                be affected by any notice to the contrary.

        f.      By acceptance of this Warrant the registered holder represents and
                warrants to the Company that such holder is acquiring this Warrant and
                will acquire any shares of Common Stock issued upon the exercise of
                this Warrant for the holder's own account with the intent of holding
                such warrant or shares for investment and without the intent of
                participating directly or indirectly in a distribution of the same.
                Any certificates for Common Stock issued upon the exercise of this
                Warrant shall bear a legend similar to the legend appearing on the
                first page of this Warrant.

        g.      The term "Fair Market Value" shall mean the average Closing Sales
                Price of the Company's Common Stock for the five (5) trading days
                immediately preceding the date of notice or exercise which relates to
                said determination of Fair Market Value.

        IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officers and its corporation seal to be affixed hereto.

        Dated: February 15, 2002

                                            INNERSPACE CORPORATION

                                            By:/s/Robert Arkin
                                               Chief Executive Officer

                                       27

                                   ASSIGNMENT

(To be Executed by the Registered Holder to effect a Transfer of the foregoing Warrant)

        FOR VALUE RECEIVED, the undersigned hereby sells, and assigns and transfers
unto the foregoing Warrant and the rights represented thereto to purchase shares
of Common Stock of INNERSPACE CORPORATION, in accordance with the terms and
conditions thereof, and does hereby irrevocably constitute and appoint
__________________________________________ Attorney to transfer the said Warrant
on the books of the Company, with full power of substitution.

___________________________________                By __________________________
                                                      Signature
___________________________________

___________________________________
___________________________________
Address

Dated:_____________________________

In the presence of:

___________________________________

                                       28

                                SUBSCRIPTION FORM

  (To be Executed by the Registered Holder to Exercise the Rights to Purchase
                   Stock evidenced by the foregoing Warrant)

TO: INNERSPACE CORPORATION

        The undersigned hereby exercises the right to purchase _______ shares of
Common Stock covered by the attached Warrant in accordance with the terms and
conditions thereof, and herewith makes payment of the Warrant Price of such
shares in full.

        The undersigned represents and warrants to you that the undersigned is
acquiring such shares for the undersigned's own account with the intent of
holding such shares for investment and without the intent of participating
directly or indirectly in a distribution of such shares.

                                              ________________________________
                                          By: ________________________________
                                              Signature

                                              ________________________________
                                              ________________________________
                                              Address

Dated: _________________.

                                       29

                             INNERSPACE CORPORATION

                          COMMON STOCK PURCHASE WARRANT

                          DATED AS OF FEBRUARY 15, 2002

                                SANDRA K. LUCIUS

                                       30

THIS WARRANT AND THE SHARES OF COMMON STOCK COVERED HEREBY (COLLECTIVELY, THE
"SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE GEORGIA SECURITIES ACT OF 1973,
AS AMENDED ("GEORGIA ACT"), IN RELIANCE UPON THE EXEMPTION PROVIDED BY SECTION
9(m) (NOW CODIFIED AS O.C.G.A. SECTION 10-5-9(13)) THEREOF, AND HAVE NOT BEEN
REGISTERED UNDER ANY OTHER STATE SECURITIES LAW OR THE SECURITIES ACT OF 1933,
AS AMENDED ("FEDERAL ACT"). THE SECURITIES WILL BE ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED, NOR WILL ANY
ASSIGNEE OR TRANSFEREE THEREOF BE RECOGNIZED BY INNERSPACE CORPORATION (THE
"COMPANY") AS HAVING ANY INTEREST IN SUCH SECURITIES, IN THE ABSENCE OF (i) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
GEORGIA ACT, OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL SHALL BE
SATISFACTORY TO THE COMPANY, THAT THE TRANSACTION BY WHICH SUCH SECURITIES WILL
BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED IS EXEMPT UNDER THE
GEORGIA ACT OR IS OTHERWISE IN COMPLIANCE WITH THE GEORGIA ACT; AND (ii) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
FEDERAL ACT, AND ANY OTHER APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF
COUNSEL, WHICH OPINION AND COUNSEL SHALL BE SATISFACTORY TO THE COMPANY, THAT
SUCH REGISTRATION IS NOT REQUIRED.

                             INNERSPACE CORPORATION
                          COMMON STOCK PURCHASE WARRANT

Warrant No. 2                                             No. of Shares - 29,600

        This certifies that, for value received, Sandra K. Lucius, hereinafter
referred to as the registered holder or the "Optionee," or her successors and
assigns, is entitled, subject to the terms and conditions hereinafter set forth,
at or before 5:00 o'clock P.M., Eastern time, on February 15, 2006, but not
thereafter, to purchase 29,600 shares of $.001 par value Common Stock (the
"Common Stock") of INNERSPACE CORPORATION, a Delaware corporation (the
"Company"), such number of shares being subject to adjustment upon the
occurrence of the contingencies set forth in this Warrant. The purchase price
payable upon the exercise of this Warrant shall be $1.00 per share, said amount
being hereinafter referred to as the "Warrant Price" and being subject to
adjustments upon the occurrence of the contingencies set forth in this Warrant.

        Upon delivery of this Warrant with the subscription form annexed hereto,
duly executed, together with payment of the Warrant Price for the shares of
Common Stock thereby purchased, at the principal office of the Company, 201
Allen Road NE, Suite 310, Atlanta, Georgia 30328-4864, or at such other address
as the Company may designate by notice in writing to the registered holder
hereof, the registered holder of this Warrant shall be entitled to receive a
certificate or certificates for the shares of Common Stock so purchased. All
shares of Common Stock which may be issued upon the exercise of this Warrant
will, upon issuance, be fully-paid and non-assessable and free from all taxes,
liens and charges with respect thereto.

        This Warrant is subject to the following terms and conditions:

                                       31

1.      Optional Exercise of Warrant. This Warrant may be exercised in whole at any
        time, or in any part from time to time, at or prior to 5:00 o'clock P.M.,
        Eastern time, on February 15, 2006, but not thereafter, as to all or any
        part of the number of whole shares of Common Stock then subject hereto.
        Payment of the Warrant Price shall be made in cash. In case of any partial
        exercise of this Warrant, the Company shall execute and deliver a new
        Warrant of like tenor and date for the balance of the shares of Common
        Stock purchasable hereunder. Upon any exercise of this Warrant, Optionee
        may, in lieu of payment of the Warrant Price in cash, surrender this
        Warrant (or any successor hereto or fraction hereof) (valued for such
        purpose at the Fair Market Value of the underlying Common Stock for which
        such Warrant is exercisable on the date of such exercise less the Warrant
        Price then in effect) and apply all or a portion of the amount so
        determined to the payment of the Warrant Price for the number of shares of
        Common Stock being purchased.

2.      Adjustment of Warrant Price and Number of Shares Purchasable Hereunder. In
        case the Company shall at any time subdivide the outstanding shares of its
        Common Stock, the Warrant Price in effect immediately prior to such
        subdivision shall be proportionately decreased, and in case the Company
        shall at any time combine the outstanding shares of its Common Stock, the
        Warrant Price in effect shall immediately prior to such combination be
        proportionately increased, effective from and after the record date of such
        subdivision or combination, as the case may be.

3.      Notice of Adjustments. Upon any adjustment of the Warrant Price and any
        increase or decrease in the number of shares of Common Stock purchasable
        upon the exercise of this Warrant, then and in each such case, the Company,
        within thirty (30) days thereafter, shall give written notice thereof to
        the registered holder of this Warrant at the address of such holder as
        shown on the books of the Company, which notice shall state the Warrant
        Price as adjusted and the increased or decreased number of shares
        purchasable upon the exercise of this Warrant, setting forth in reasonable
        detail the method of calculation of each. The holder of the Warrant shall
        have 10 days in which to review the proposed adjustment and to object to
        the proposed adjustment by notifying the Company in writing of such
        objection, setting forth in reasonable detail the reasons for such
        objection. If the holder fails to object to the proposed adjustment during
        such 10-day period the proposed adjustment shall become final. If the
        holder objects to the proposed adjustment then the Company and the holder
        shall attempt to reconcile their differences and if unable to do so such
        adjustment shall be determined by the Company's independent accountants
        whose determination shall be final.

4.      Notice of Exercise of Option. This Option may be exercised by the Optionee
        by a written notice signed by the Optionee, and delivered or mailed to the
        Company to the attention of the President. The notice shall specify the
        number of shares of Stock which the Optionee elects to purchase hereunder,
        and be accompanied by (i) a certified or cashier's check payable to the
        Company in payment of the total Exercise Price applicable to such shares as
        provided herein, (ii) shares of Stock owned by Optionee and duly endorsed
        or accompanied by stock transfer powers having a Fair Market Value equal to
        the total Exercise Price applicable to such shares purchased hereunder, or
        (iii) a certified or cashier's check accompanied by a certificate or

                                       32

        certificates representing the number of shares of Stock whose Fair Market
        Value when added to the amount of the check equals the total Exercise Price
        applicable to such shares purchased hereunder. Upon receipt of an such
        notice and accompanying payment, the Company agrees to issue to the
        Optionee stock certificates for the number of shares specified in such
        notice registered in the name of the Optionee.

5.      Charges, Taxes and Expenses. The issuance of certificates for shares of
        Common Stock upon any exercise of this Warrant shall be made without charge
        to the holder hereof for any tax or other expense in respect to the
        issuance of such certificates, all of which taxes and expenses shall be
        paid by the Company, and such certificates shall be issued in the name of,
        or in such name or names as may be directed by, the holder of this Warrant;
        provided, however, that in the event that certificates for shares of Common
        Stock are to be issued in a name other than the name of the holder of this
        Warrant, this Warrant when surrendered for exercise shall be accompanied by
        an instrument of transfer in form satisfactory to the Company, duly
        executed by the holder hereof in person or by an attorney duly authorized
        in writing.

6.      Certain Obligations of the Company. The Company will not, by amendment of
        its Certificate of Incorporation or through reorganization, consolidation,
        merger, dissolution or sale of assets, or by any other voluntary act or
        deed, avoid or seek to avoid the performance or observance of any of the
        covenants, stipulations or conditions to be performed or observed by the
        Company, but will at all times in good faith assist, insofar as it is able,
        in the carrying out of all provisions of this Warrant and in the taking of
        all other action which may be necessary in order to protect the rights of
        the holder of this Warrant against dilution. Without limiting the
        generality of the foregoing, the Company agrees that it will not establish
        or increase the par value of the shares of any Common Stock which are at
        the time issuable upon exercise of this Warrant above the then prevailing
        Warrant Price hereunder and that, before taking any action which would
        cause an adjustment reducing the Warrant Price hereunder below the then par
        value, if any, of the shares of any Common Stock issuable upon exercise
        hereof, the Company will take any corporate action which may, in the
        opinion of its counsel, be necessary in order that the Company may validly
        and legally issue fully-paid and non-assessable shares of such Common Stock
        at the Warrant Price as so adjusted.

7.      Miscellaneous.

        a.      The Company covenants that it will at all times reserve and keep
                available, solely for the purpose of issue upon the exercise hereof, a
                sufficient number of shares of Common Stock to permit the exercise
                hereof in full and a sufficient number of shares of Common Stock to
                permit the conversion of all such shares of Common Stock.

        b.      The terms of this Warrant shall be binding upon and shall inure to the
                benefit of any successors or assigns of the Company and of the holder
                or holders hereof and of the Common Stock issued or issuable on the
                exercise hereof.

                                       33

        c.      No holder of this Warrant, as such, shall be entitled under this
                Warrant to vote or receive dividends (except as provided in paragraph
                2 hereof) or be deemed to be a shareholder of the Company for any
                purpose.

        d.      This Warrant may be divided into separate Warrants covering one share
                of the Common Stock or any whole multiple thereof, for the total
                number of shares of Common Stock then subject to this Warrant at any
                time, or from time to time, upon the request of the registered holder
                of this Warrant and the surrender of the same to the Company for such
                purpose. Such subdivided Warrants shall be issued promptly by the
                Company following any such request and shall be of the same form and
                tenor as this Warrant, except for any requested change in the name of
                the registered holder stated herein.

        e.      Except as otherwise provided herein, this Warrant and all rights
                hereunder are transferable by the registered holder hereof in person
                or by duly authorized attorney on the books of the Company upon
                surrender of this Warrant, properly endorsed, to the Company. The
                Company may deem and treat the registered holder of this Warrant at
                any time as the absolute owner hereof for all purposes and shall not
                be affected by any notice to the contrary.

        f.      By acceptance of this Warrant the registered holder represents and
                warrants to the Company that such holder is acquiring this Warrant and
                will acquire any shares of Common Stock issued upon the exercise of
                this Warrant for the holder's own account with the intent of holding
                such warrant or shares for investment and without the intent of
                participating directly or indirectly in a distribution of the same.
                Any certificates for Common Stock issued upon the exercise of this
                Warrant shall bear a legend similar to the legend appearing on the
                first page of this Warrant.

        g.      The term "Fair Market Value" shall mean the average Closing Sales
                Price of the Company's Common Stock for the five (5) trading days
                immediately preceding the date of notice or exercise which relates to
                said determination of Fair Market Value.

        IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officers and its corporation seal to be affixed hereto.

        Dated: February 15, 2002

                                            INNERSPACE CORPORATION

                                            By:/s/ Robert D. Arkin
                                               Chief Executive Officer

                                       34

                                   ASSIGNMENT

(To be Executed by the Registered Holder to effect a Transfer of the foregoing Warrant)

        FOR VALUE RECEIVED, the undersigned hereby sells, and assigns and transfers
unto the foregoing Warrant and the rights represented thereto to purchase shares
of Common Stock of INNERSPACE CORPORATION, in accordance with the terms and
conditions thereof, and does hereby irrevocably constitute and appoint
__________________________________________ Attorney to transfer the said Warrant
on the books of the Company, with full power of substitution.

___________________________________                By __________________________
                                                      Signature
___________________________________

___________________________________
___________________________________
Address

Dated:_____________________________

In the presence of:

___________________________________

                                       35

                                SUBSCRIPTION FORM

  (To be Executed by the Registered Holder to Exercise the Rights to Purchase
                   Stock evidenced by the foregoing Warrant)

TO: INNERSPACE CORPORATION

        The undersigned hereby exercises the right to purchase _______ shares of
Common Stock covered by the attached Warrant in accordance with the terms and
conditions thereof, and herewith makes payment of the Warrant Price of such
shares in full.

        The undersigned represents and warrants to you that the undersigned is
acquiring such shares for the undersigned's own account with the intent of
holding such shares for investment and without the intent of participating
directly or indirectly in a distribution of such shares.

                                              ________________________________
                                          By: ________________________________
                                              Signature

                                              ________________________________
                                              ________________________________
                                              Address

Dated: _________________.

                                       36

                             INNERSPACE CORPORATION

                          COMMON STOCK PURCHASE WARRANT

                          DATED AS OF FEBRUARY 15, 2002

          WILLIAM W. ROGERS JR. AND ELIZABETH H. ROGERS, JOINT TENANTS

                                       37

THIS WARRANT AND THE SHARES OF COMMON STOCK COVERED HEREBY (COLLECTIVELY, THE
"SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE GEORGIA SECURITIES ACT OF 1973,
AS AMENDED ("GEORGIA ACT"), IN RELIANCE UPON THE EXEMPTION PROVIDED BY SECTION
9(m) (NOW CODIFIED AS O.C.G.A. SECTION 10-5-9(13)) THEREOF, AND HAVE NOT BEEN
REGISTERED UNDER ANY OTHER STATE SECURITIES LAW OR THE SECURITIES ACT OF 1933,
AS AMENDED ("FEDERAL ACT"). THE SECURITIES WILL BE ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED, NOR WILL ANY
ASSIGNEE OR TRANSFEREE THEREOF BE RECOGNIZED BY INNERSPACE CORPORATION (THE
"COMPANY") AS HAVING ANY INTEREST IN SUCH SECURITIES, IN THE ABSENCE OF (i) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
GEORGIA ACT, OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL SHALL BE
SATISFACTORY TO THE COMPANY, THAT THE TRANSACTION BY WHICH SUCH SECURITIES WILL
BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED IS EXEMPT UNDER THE
GEORGIA ACT OR IS OTHERWISE IN COMPLIANCE WITH THE GEORGIA ACT; AND (ii) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
FEDERAL ACT, AND ANY OTHER APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF
COUNSEL, WHICH OPINION AND COUNSEL SHALL BE SATISFACTORY TO THE COMPANY, THAT
SUCH REGISTRATION IS NOT REQUIRED.

                             INNERSPACE CORPORATION
                          COMMON STOCK PURCHASE WARRANT

Warrant No. 3                                             No. of Shares - 29,600

        This certifies that, for value received, William W. Rogers Jr. and
Elizabeth H. Rogers, joint tenants with right of survivorship, hereinafter
referred to collectively as the registered holder or the "Optionee," or their
successors and assigns, is entitled, subject to the terms and conditions
hereinafter set forth, at or before 5:00 o'clock P.M., Eastern time, on February
15, 2006, but not thereafter, to purchase 29,600 shares of $.001 par value
Common Stock (the "Common Stock") of INNERSPACE CORPORATION, a Delaware
corporation (the "Company"), such number of shares being subject to adjustment
upon the occurrence of the contingencies set forth in this Warrant. The purchase
price payable upon the exercise of this Warrant shall be $1.00 per share, said
amount being hereinafter referred to as the "Warrant Price" and being subject to
adjustments upon the occurrence of the contingencies set forth in this Warrant.

        Upon delivery of this Warrant with the subscription form annexed hereto,
duly executed, together with payment of the Warrant Price for the shares of
Common Stock thereby purchased, at the principal office of the Company, 201
Allen Road NE, Suite 310, Atlanta, Georgia 30328-4864, or at such other address
as the Company may designate by notice in writing to the registered holder
hereof, the registered holder of this Warrant shall be entitled to receive a
certificate or certificates for the shares of Common Stock so purchased. All
shares of Common Stock which may be issued upon the exercise of this Warrant
will, upon issuance, be fully-paid and non-assessable and free from all taxes,
liens and charges with respect thereto.

                                       38

        This Warrant is subject to the following terms and conditions:

1.      Optional Exercise of Warrant. This Warrant may be exercised in whole at any
        time, or in any part from time to time, at or prior to 5:00 o'clock P.M.,
        Eastern time, on February 15, 2006, but not thereafter, as to all or any
        part of the number of whole shares of Common Stock then subject hereto.
        Payment of the Warrant Price shall be made in cash. In case of any partial
        exercise of this Warrant, the Company shall execute and deliver a new
        Warrant of like tenor and date for the balance of the shares of Common
        Stock purchasable hereunder. Upon any exercise of this Warrant, Optionee
        may, in lieu of payment of the Warrant Price in cash, surrender this
        Warrant (or any successor hereto or fraction hereof) (valued for such
        purpose at the Fair Market Value of the underlying Common Stock for which
        such Warrant is exercisable on the date of such exercise less the Warrant
        Price then in effect) and apply all or a portion of the amount so
        determined to the payment of the Warrant Price for the number of shares of
        Common Stock being purchased.

2.      Adjustment of Warrant Price and Number of Shares Purchasable Hereunder. In
        case the Company shall at any time subdivide the outstanding shares of its
        Common Stock, the Warrant Price in effect immediately prior to such
        subdivision shall be proportionately decreased, and in case the Company
        shall at any time combine the outstanding shares of its Common Stock, the
        Warrant Price in effect shall immediately prior to such combination be
        proportionately increased, effective from and after the record date of such
        subdivision or combination, as the case may be.

3.      Notice of Adjustments. Upon any adjustment of the Warrant Price and any
        increase or decrease in the number of shares of Common Stock purchasable
        upon the exercise of this Warrant, then and in each such case, the Company,
        within thirty (30) days thereafter, shall give written notice thereof to
        the registered holder of this Warrant at the address of such holder as
        shown on the books of the Company, which notice shall state the Warrant
        Price as adjusted and the increased or decreased number of shares
        purchasable upon the exercise of this Warrant, setting forth in reasonable
        detail the method of calculation of each. The holder of the Warrant shall
        have 10 days in which to review the proposed adjustment and to object to
        the proposed adjustment by notifying the Company in writing of such
        objection, setting forth in reasonable detail the reasons for such
        objection. If the holder fails to object to the proposed adjustment during
        such 10-day period the proposed adjustment shall become final. If the
        holder objects to the proposed adjustment then the Company and the holder
        shall attempt to reconcile their differences and if unable to do so such
        adjustment shall be determined by the Company's independent accountants
        whose determination shall be final.

4.      Notice of Exercise of Option. This Option may be exercised by the Optionee
        by a written notice signed by the Optionee, and delivered or mailed to the
        Company to the attention of the President. The notice shall specify the
        number of shares of Stock which the Optionee elects to purchase hereunder,
        and be accompanied by (i) a certified or cashier's check payable to the
        Company in payment of the total Exercise Price applicable to such shares as
        provided herein, (ii) shares of Stock owned by Optionee and duly endorsed
        or accompanied by stock transfer powers having a Fair Market Value equal to
        the total Exercise Price applicable to such shares purchased hereunder, or

                                       39

        (iii) a certified or cashier's check accompanied by a certificate or
        certificates representing the number of shares of Stock whose Fair Market
        Value when added to the amount of the check equals the total Exercise Price
        applicable to such shares purchased hereunder. Upon receipt of an such
        notice and accompanying payment, the Company agrees to issue to the
        Optionee stock certificates for the number of shares specified in such
        notice registered in the name of the Optionee.

5.      Charges, Taxes and Expenses. The issuance of certificates for shares of
        Common Stock upon any exercise of this Warrant shall be made without charge
        to the holder hereof for any tax or other expense in respect to the
        issuance of such certificates, all of which taxes and expenses shall be
        paid by the Company, and such certificates shall be issued in the name of,
        or in such name or names as may be directed by, the holder of this Warrant;
        provided, however, that in the event that certificates for shares of Common
        Stock are to be issued in a name other than the name of the holder of this
        Warrant, this Warrant when surrendered for exercise shall be accompanied by
        an instrument of transfer in form satisfactory to the Company, duly
        executed by the holder hereof in person or by an attorney duly authorized
        in writing.

6.      Certain Obligations of the Company. The Company will not, by amendment of
        its Certificate of Incorporation or through reorganization, consolidation,
        merger, dissolution or sale of assets, or by any other voluntary act or
        deed, avoid or seek to avoid the performance or observance of any of the
        covenants, stipulations or conditions to be performed or observed by the
        Company, but will at all times in good faith assist, insofar as it is able,
        in the carrying out of all provisions of this Warrant and in the taking of
        all other action which may be necessary in order to protect the rights of
        the holder of this Warrant against dilution. Without limiting the
        generality of the foregoing, the Company agrees that it will not establish
        or increase the par value of the shares of any Common Stock which are at
        the time issuable upon exercise of this Warrant above the then prevailing
        Warrant Price hereunder and that, before taking any action which would
        cause an adjustment reducing the Warrant Price hereunder below the then par
        value, if any, of the shares of any Common Stock issuable upon exercise
        hereof, the Company will take any corporate action which may, in the
        opinion of its counsel, be necessary in order that the Company may validly
        and legally issue fully-paid and non-assessable shares of such Common Stock
        at the Warrant Price as so adjusted.

7.      Miscellaneous.

        a.      The Company covenants that it will at all times reserve and keep
                available, solely for the purpose of issue upon the exercise hereof, a
                sufficient number of shares of Common Stock to permit the exercise
                hereof in full and a sufficient number of shares of Common Stock to
                permit the conversion of all such shares of Common Stock.

        b.      The terms of this Warrant shall be binding upon and shall inure to the
                benefit of any successors or assigns of the Company and of the holder
                or holders hereof and of the Common Stock issued or issuable on the
                exercise hereof.

                                       40

        c.      No holder of this Warrant, as such, shall be entitled under this
                Warrant to vote or receive dividends (except as provided in paragraph
                2 hereof) or be deemed to be a shareholder of the Company for any
                purpose.

        d.      This Warrant may be divided into separate Warrants covering one share
                of the Common Stock or any whole multiple thereof, for the total
                number of shares of Common Stock then subject to this Warrant at any
                time, or from time to time, upon the request of the registered holder
                of this Warrant and the surrender of the same to the Company for such
                purpose. Such subdivided Warrants shall be issued promptly by the
                Company following any such request and shall be of the same form and
                tenor as this Warrant, except for any requested change in the name of
                the registered holder stated herein.

        e.      Except as otherwise provided herein, this Warrant and all rights
                hereunder are transferable by the registered holder hereof in person
                or by duly authorized attorney on the books of the Company upon
                surrender of this Warrant, properly endorsed, to the Company. The
                Company may deem and treat the registered holder of this Warrant at
                any time as the absolute owner hereof for all purposes and shall not
                be affected by any notice to the contrary.

        f.      By acceptance of this Warrant the registered holder represents and
                warrants to the Company that such holder is acquiring this Warrant and
                will acquire any shares of Common Stock issued upon the exercise of
                this Warrant for the holder's own account with the intent of holding
                such warrant or shares for investment and without the intent of
                participating directly or indirectly in a distribution of the same.
                Any certificates for Common Stock issued upon the exercise of this
                Warrant shall bear a legend similar to the legend appearing on the
                first page of this Warrant.

        g.      The term "Fair Market Value" shall mean the average Closing Sales
                Price of the Company's Common Stock for the five (5) trading days
                immediately preceding the date of notice or exercise which relates to
                said determination of Fair Market Value.

        IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officers and its corporation seal to be affixed hereto.

        Dated: February 15, 2002

                                            INNERSPACE CORPORATION

                                            By:/s/ Robert D. Arkin
                                               Chief Executive Officer

                                       41

                                   ASSIGNMENT

(To be Executed by the Registered Holder to effect a Transfer of the foregoing Warrant)

        FOR VALUE RECEIVED, the undersigned hereby sells, and assigns and transfers
unto the foregoing Warrant and the rights represented thereto to purchase shares
of Common Stock of INNERSPACE CORPORATION, in accordance with the terms and
conditions thereof, and does hereby irrevocably constitute and appoint
__________________________________________ Attorney to transfer the said Warrant
on the books of the Company, with full power of substitution.

___________________________________                By __________________________
                                                      Signature
___________________________________

___________________________________
___________________________________
Address

Dated:_____________________________

In the presence of:

___________________________________

                                       42

                                SUBSCRIPTION FORM

  (To be Executed by the Registered Holder to Exercise the Rights to Purchase
                   Stock evidenced by the foregoing Warrant)

TO: INNERSPACE CORPORATION

        The undersigned hereby exercises the right to purchase _______ shares of
Common Stock covered by the attached Warrant in accordance with the terms and
conditions thereof, and herewith makes payment of the Warrant Price of such
shares in full.

        The undersigned represents and warrants to you that the undersigned is
acquiring such shares for the undersigned's own account with the intent of
holding such shares for investment and without the intent of participating
directly or indirectly in a distribution of such shares.

                                              ________________________________
                                          By: ________________________________
                                              Signature

                                              ________________________________
                                              ________________________________
                                              Address

Dated: _________________.

                                       43

                             INNERSPACE CORPORATION

                          COMMON STOCK PURCHASE WARRANT

                          DATED AS OF FEBRUARY 15, 2002

                                KENNETH R. CROWE

                                       44

THIS WARRANT AND THE SHARES OF COMMON STOCK COVERED HEREBY (COLLECTIVELY, THE
"SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE GEORGIA SECURITIES ACT OF 1973,
AS AMENDED ("GEORGIA ACT"), IN RELIANCE UPON THE EXEMPTION PROVIDED BY SECTION
9(m) (NOW CODIFIED AS O.C.G.A. SECTION 10-5-9(13)) THEREOF, AND HAVE NOT BEEN
REGISTERED UNDER ANY OTHER STATE SECURITIES LAW OR THE SECURITIES ACT OF 1933,
AS AMENDED ("FEDERAL ACT"). THE SECURITIES WILL BE ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED, NOR WILL ANY
ASSIGNEE OR TRANSFEREE THEREOF BE RECOGNIZED BY INNERSPACE CORPORATION (THE
"COMPANY") AS HAVING ANY INTEREST IN SUCH SECURITIES, IN THE ABSENCE OF (i) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
GEORGIA ACT, OR AN OPINION OF COUNSEL, WHICH OPINION AND COUNSEL SHALL BE
SATISFACTORY TO THE COMPANY, THAT THE TRANSACTION BY WHICH SUCH SECURITIES WILL
BE OFFERED FOR SALE, HYPOTHECATED, SOLD OR TRANSFERRED IS EXEMPT UNDER THE
GEORGIA ACT OR IS OTHERWISE IN COMPLIANCE WITH THE GEORGIA ACT; AND (ii) AN
EFFECTIVE REGISTRATION STATEMENT WITH RESPECT TO THE SECURITIES UNDER THE
FEDERAL ACT, AND ANY OTHER APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF
COUNSEL, WHICH OPINION AND COUNSEL SHALL BE SATISFACTORY TO THE COMPANY, THAT
SUCH REGISTRATION IS NOT REQUIRED.

                             INNERSPACE CORPORATION
                          COMMON STOCK PURCHASE WARRANT

Warrant No 4                                              No. of Shares - 20,800

        This certifies that, for value received, Kenneth R. Crowe, hereinafter
referred to as the registered holder or the "Optionee," or his successors and
assigns, is entitled, subject to the terms and conditions hereinafter set forth,
at or before 5:00 o'clock P.M., Eastern time, on February 15, 2006, but not
thereafter, to purchase 20,800 shares of $.001 par value Common Stock (the
"Common Stock") of INNERSPACE CORPORATION, a Delaware corporation (the
"Company"), such number of shares being subject to adjustment upon the
occurrence of the contingencies set forth in this Warrant. The purchase price
payable upon the exercise of this Warrant shall be $1.00 per share, said amount
being hereinafter referred to as the "Warrant Price" and being subject to
adjustments upon the occurrence of the contingencies set forth in this Warrant.

        Upon delivery of this Warrant with the subscription form annexed hereto,
duly executed, together with payment of the Warrant Price for the shares of
Common Stock thereby purchased, at the principal office of the Company, 201
Allen Road NE, Suite 310, Atlanta, Georgia 30328-4864, or at such other address
as the Company may designate by notice in writing to the registered holder
hereof, the registered holder of this Warrant shall be entitled to receive a
certificate or certificates for the shares of Common Stock so purchased. All
shares of Common Stock which may be issued upon the exercise of this Warrant
will, upon issuance, be fully-paid and non-assessable and free from all taxes,
liens and charges with respect thereto.

        This Warrant is subject to the following terms and conditions:

                                       45

1.      Optional Exercise of Warrant. This Warrant may be exercised in whole at any
        time, or in any part from time to time, at or prior to 5:00 o'clock P.M.,
        Eastern time, on February 15, 2006, but not thereafter, as to all or any
        part of the number of whole shares of Common Stock then subject hereto.
        Payment of the Warrant Price shall be made in cash. In case of any partial
        exercise of this Warrant, the Company shall execute and deliver a new
        Warrant of like tenor and date for the balance of the shares of Common
        Stock purchasable hereunder. Upon any exercise of this Warrant, Optionee
        may, in lieu of payment of the Warrant Price in cash, surrender this
        Warrant (or any successor hereto or fraction hereof) (valued for such
        purpose at the Fair Market Value of the underlying Common Stock for which
        such Warrant is exercisable on the date of such exercise less the Warrant
        Price then in effect) and apply all or a portion of the amount so
        determined to the payment of the Warrant Price for the number of shares of
        Common Stock being purchased.

2.      Adjustment of Warrant Price and Number of Shares Purchasable Hereunder. In
        case the Company shall at any time subdivide the outstanding shares of its
        Common Stock, the Warrant Price in effect immediately prior to such
        subdivision shall be proportionately decreased, and in case the Company
        shall at any time combine the outstanding shares of its Common Stock, the
        Warrant Price in effect shall immediately prior to such combination be
        proportionately increased, effective from and after the record date of such
        subdivision or combination, as the case may be.

3.      Notice of Adjustments. Upon any adjustment of the Warrant Price and any
        increase or decrease in the number of shares of Common Stock purchasable
        upon the exercise of this Warrant, then and in each such case, the Company,
        within thirty (30) days thereafter, shall give written notice thereof to
        the registered holder of this Warrant at the address of such holder as
        shown on the books of the Company, which notice shall state the Warrant
        Price as adjusted and the increased or decreased number of shares
        purchasable upon the exercise of this Warrant, setting forth in reasonable
        detail the method of calculation of each. The holder of the Warrant shall
        have 10 days in which to review the proposed adjustment and to object to
        the proposed adjustment by notifying the Company in writing of such
        objection, setting forth in reasonable detail the reasons for such
        objection. If the holder fails to object to the proposed adjustment during
        such 10-day period the proposed adjustment shall become final. If the
        holder objects to the proposed adjustment then the Company and the holder
        shall attempt to reconcile their differences and if unable to do so such
        adjustment shall be determined by the Company's independent accountants
        whose determination shall be final.

4.      Notice of Exercise of Option. This Option may be exercised by the Optionee
        by a written notice signed by the Optionee, and delivered or mailed to the
        Company to the attention of the President. The notice shall specify the
        number of shares of Stock which the Optionee elects to purchase hereunder,
        and be accompanied by (i) a certified or cashier's check payable to the
        Company in payment of the total Exercise Price applicable to such shares as
        provided herein, (ii) shares of Stock owned by Optionee and duly endorsed
        or accompanied by stock transfer powers having a Fair Market Value equal to
        the total Exercise Price applicable to such shares purchased hereunder, or
        (iii) a certified or cashier's check accompanied by a certificate or

                                       46

        certificates representing the number of shares of Stock whose Fair Market
        Value when added to the amount of the check equals the total Exercise Price
        applicable to such shares purchased hereunder. Upon receipt of an such
        notice and accompanying payment, the Company agrees to issue to the
        Optionee stock certificates for the number of shares specified in such
        notice registered in the name of the Optionee.

5.      Charges, Taxes and Expenses. The issuance of certificates for shares of
        Common Stock upon any exercise of this Warrant shall be made without charge
        to the holder hereof for any tax or other expense in respect to the
        issuance of such certificates, all of which taxes and expenses shall be
        paid by the Company, and such certificates shall be issued in the name of,
        or in such name or names as may be directed by, the holder of this Warrant;
        provided, however, that in the event that certificates for shares of Common
        Stock are to be issued in a name other than the name of the holder of this
        Warrant, this Warrant when surrendered for exercise shall be accompanied by
        an instrument of transfer in form satisfactory to the Company, duly
        executed by the holder hereof in person or by an attorney duly authorized
        in writing.

6.      Certain Obligations of the Company. The Company will not, by amendment of
        its Certificate of Incorporation or through reorganization, consolidation,
        merger, dissolution or sale of assets, or by any other voluntary act or
        deed, avoid or seek to avoid the performance or observance of any of the
        covenants, stipulations or conditions to be performed or observed by the
        Company, but will at all times in good faith assist, insofar as it is able,
        in the carrying out of all provisions of this Warrant and in the taking of
        all other action which may be necessary in order to protect the rights of
        the holder of this Warrant against dilution. Without limiting the
        generality of the foregoing, the Company agrees that it will not establish
        or increase the par value of the shares of any Common Stock which are at
        the time issuable upon exercise of this Warrant above the then prevailing
        Warrant Price hereunder and that, before taking any action which would
        cause an adjustment reducing the Warrant Price hereunder below the then par
        value, if any, of the shares of any Common Stock issuable upon exercise
        hereof, the Company will take any corporate action which may, in the
        opinion of its counsel, be necessary in order that the Company may validly
        and legally issue fully-paid and non-assessable shares of such Common Stock
        at the Warrant Price as so adjusted.

7.      Miscellaneous.

        a.      The Company covenants that it will at all times reserve and keep
                available, solely for the purpose of issue upon the exercise hereof, a
                sufficient number of shares of Common Stock to permit the exercise
                hereof in full and a sufficient number of shares of Common Stock to
                permit the conversion of all such shares of Common Stock.

        b.      The terms of this Warrant shall be binding upon and shall inure to the
                benefit of any successors or assigns of the Company and of the holder
                or holders hereof and of the Common Stock issued or issuable on the
                exercise hereof.

                                       47

        c.      No holder of this Warrant, as such, shall be entitled under this
                Warrant to vote or receive dividends (except as provided in paragraph
                2 hereof) or be deemed to be a shareholder of the Company for any
                purpose.

        d.      This Warrant may be divided into separate Warrants covering one share
                of the Common Stock or any whole multiple thereof, for the total
                number of shares of Common Stock then subject to this Warrant at any
                time, or from time to time, upon the request of the registered holder
                of this Warrant and the surrender of the same to the Company for such
                purpose. Such subdivided Warrants shall be issued promptly by the
                Company following any such request and shall be of the same form and
                tenor as this Warrant, except for any requested change in the name of
                the registered holder stated herein.

        e.      Except as otherwise provided herein, this Warrant and all rights
                hereunder are transferable by the registered holder hereof in person
                or by duly authorized attorney on the books of the Company upon
                surrender of this Warrant, properly endorsed, to the Company. The
                Company may deem and treat the registered holder of this Warrant at
                any time as the absolute owner hereof for all purposes and shall not
                be affected by any notice to the contrary.

        f.      By acceptance of this Warrant the registered holder represents and
                warrants to the Company that such holder is acquiring this Warrant and
                will acquire any shares of Common Stock issued upon the exercise of
                this Warrant for the holder's own account with the intent of holding
                such warrant or shares for investment and without the intent of
                participating directly or indirectly in a distribution of the same.
                Any certificates for Common Stock issued upon the exercise of this
                Warrant shall bear a legend similar to the legend appearing on the
                first page of this Warrant.

        g.      The term "Fair Market Value" shall mean the average Closing Sales
                Price of the Company's Common Stock for the five (5) trading days
                immediately preceding the date of notice or exercise which relates to
                said determination of Fair Market Value.

        IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officers and its corporation seal to be affixed hereto.

        Dated: February 15, 2002

                                            INNERSPACE CORPORATION

                                            By:/s/ Robert D. Arkin
                                               Chief Executive Officer

                                       48

                                   ASSIGNMENT

(To be Executed by the Registered Holder to effect a Transfer of the foregoing Warrant)

        FOR VALUE RECEIVED, the undersigned hereby sells, and assigns and transfers
unto the foregoing Warrant and the rights represented thereto to purchase shares
of Common Stock of INNERSPACE CORPORATION, in accordance with the terms and
conditions thereof, and does hereby irrevocably constitute and appoint
__________________________________________ Attorney to transfer the said Warrant
on the books of the Company, with full power of substitution.

___________________________________                By __________________________
                                                      Signature
___________________________________

___________________________________
___________________________________
Address

Dated:_____________________________

In the presence of:

___________________________________

                                       49

                                SUBSCRIPTION FORM

  (To be Executed by the Registered Holder to Exercise the Rights to Purchase
                   Stock evidenced by the foregoing Warrant)

TO: INNERSPACE CORPORATION

        The undersigned hereby exercises the right to purchase _______ shares of
Common Stock covered by the attached Warrant in accordance with the terms and
conditions thereof, and herewith makes payment of the Warrant Price of such
shares in full.

        The undersigned represents and warrants to you that the undersigned is
acquiring such shares for the undersigned's own account with the intent of
holding such shares for investment and without the intent of participating
directly or indirectly in a distribution of such shares.

                                              ________________________________
                                          By: ________________________________
                                              Signature

                                              ________________________________
                                              ________________________________
                                              Address

Dated: _________________.

                                       50

                                    EXHIBIT D
                               VESTING CONDITIONS

The right of each registered holder to exercise his or her rights under the
Warrant Agreements attached to the License Agreement as Exhibit C will vest upon
satisfaction by the Licensor of the following conditions:

        1. Provide and load base data for primary care internal medicine/family
           practice by not later than February 28, 2002;

        2. assist in loading the Licensed Program on Licensee's servers by
           February 28, 2002;

        3. within five working days after receiving mutually acceptable
           specifications signed and approved by both Licensor and Licensee,
           provide a time and cost estimate for, and within 30 days of the agreed
           upon completion date, complete and deliver to Licensee, each of the
           following:

                a. a superbill to meet Licensed Program integration requirements;

                b. island codes;

                c. a database for at least one proof of concept site;;

                d. precertification capability to meet Licensed Program marketing
                   requirements;

                e. modifications to Licensed Program so that Licensee can reasonably
                   operate the Licensed Program from within Licensee's Internet
                   Portal to meet marketing and customer rollout requirements;

                f. training tools to meet customer rollout requirements; and

                g. work aided drawings for ortho, optham and other enhanced
                   specialty support to meet Licensed Program marketing
                   requirements.

Notwithstanding the foregoing conditions, the registered holders' entitlement to
exercise their rights under the Warrant Agreements will vest on May 15, 2002 if
the Licensee has failed to provide mutually acceptable specifications relating
to each of Items 3.a through 3.g above. If Licensee has provide said
specifications and the scope of work requires the professional services to
extend beyond August 15, 2002, the registered holders' entitlement to exercise
their rights under the Warrant Agreements will vest on August 15, 2002.

                                       51

                                   EXHIBIT E
                          SOURCE CODE ESCROW AGREEMENT

This Agreement is effective February 15, 2002 between Raiford & Dixon, LLP
("Escrow Agent"), The KRC Group, Inc., a Delaware corporation ("Depositor"), and
InnerSpace Corporation, a Delaware corporation (the "Preferred Beneficiary").
Escrow Agent, Depositor and the Preferred Beneficiary are hereinafter referred
to collectively as the "parties."

                                    RECITALS:

A. Depositor and Preferred Beneficiary have entered or will enter into a
   License Agreement regarding certain proprietary technology of Depositor
   (referred to in this Agreement as "the License Agreement").

B. Depositor desires to avoid disclosure of its proprietary technology except
   under certain limited circumstances.

C. The availability of the proprietary technology of Depositor is critical to
   Preferred Beneficiary in the conduct of its business and, therefore,
   Preferred Beneficiary needs access to the proprietary technology under
   certain limited circumstances.

D. Depositor and Preferred Beneficiary desire to establish an escrow with
   Escrow Agent to provide for the retention, administration and controlled
   access of certain proprietary technology materials of Depositor.

E. The parties desire this Agreement to be supplementary to the License
   Agreement pursuant to11 United States Bankruptcy Code, Section 365(n).

                                    ARTICLE 1
                                    DEPOSITS

1.1 Obligation to Make Deposit. Upon the signing of this Agreement by the
    parties, including the signing of the Acceptance Form, Depositor shall
    deliver to Escrow Agent the proprietary technology and other materials
    ("Deposit Materials") required to be deposited by the License Agreement or,
    if the License Agreement does not identify the materials to be deposited
    with Escrow Agent, then such materials will be identified on Exhibit 1. If
    Exhibit 1 is applicable, it is to be prepared and signed by Depositor and
    Preferred Beneficiary. Escrow Agent shall have no obligation with respect
    to the preparation, signing or delivery of Exhibit 1.

1.2 Identification of Tangible Media. Prior to the delivery of the Deposit
    Materials to Escrow Agent, Depositor shall conspicuously label for
    identification each document, magnetic tape, disk, or other tangible media
    upon which the Deposit Materials are written or stored. Additionally,
    Depositor shall complete Exhibit 2 to this Agreement by listing each such
    tangible media by the item label description, the type of media and the
    quantity. Exhibit 2 shall be signed by Depositor and delivered to Escrow
    Agent with the Deposit Materials. Unless and until Depositor makes the
    initial deposit with Escrow Agent, Escrow Agent shall have no obligation

                                       52

    with respect to this Agreement, except the obligation to notify the parties
    regarding the status of the account as required in Section 2.2 below.

1.3 Deposit Inspection. When Escrow Agent receives the Deposit Materials and
    the information contained in Exhibit 2, Escrow Agent will conduct a deposit
    inspection by visually matching the labeling of the tangible media
    containing the Deposit Materials to the item descriptions and quantity
    listed on Exhibit 2.

1.4 Acceptance of Deposit. At completion of the deposit inspection, if Escrow
    Agent determines that the labeling of the tangible media matches the item
    descriptions and quantity on Exhibit 2, Escrow Agent will date and sign
    Exhibit 2 and mail a copy thereof to Depositor and Preferred Beneficiary.
    If Escrow Agent determines that the labeling does not match the item
    descriptions or quantity on Exhibit 2, Escrow Agent will (a) note the
    discrepancies in writing on Exhibit 2; (b) date and sign Exhibit 2 with the
    exceptions noted; and (c) mail a copy of Exhibit 2 to Depositor and
    Preferred Beneficiary. Escrow Agent's acceptance of the deposit occurs upon
    the signing of Exhibit 2 by Escrow Agent. Delivery of the signed Exhibit 2
    to Preferred Beneficiary is Preferred Beneficiary's notice that the Deposit
    Materials have been received and accepted by Escrow Agent.

1.5 Depositor's Representations. Depositor represents as follows:

        a. Depositor lawfully possesses all of the Deposit Materials deposited
           with Escrow Agent;

        b. With respect to all of the Deposit Materials, Depositor has the right
           and authority to grant to Escrow Agent and Preferred Beneficiary the
           rights as provided in this Agreement;

        c. The Deposit Materials are not subject to any lien or other
           encumbrance;

        d. The Deposit Materials consist of the proprietary technology and other
           materials identified either in the License Agreement or Exhibit 1, as
           the case may be; and

        e. The Deposit Materials are readable and useable in their current form
           or, if any portion of the Deposit Materials is encrypted, the
           decryption tools and decryption keys have also been deposited.

1.6 Verification. Verification determines, in different levels of detail, the
    accuracy, completeness, sufficiency and quality of the Deposit Materials.

        a. Escrow Agent shall perform an Initial Verification of the Deposit
           Materials upon the initial deposit and for each update. An Initial
           Verification is defined as follows: Escrow Agent will cause Chris
           Ivaliotes or if Mr. Ivaliotes is unavailable a technically qualified
           Escrow Agent designee to evaluate the Deposit Materials in order to
           identify (a) the hardware and software configurations reasonably
           necessary to maintain the Deposit Materials; (b) the hardware and
           software configurations reasonably necessary to compile the Deposit

                                       53

           Materials; and (c) the compilation instructions. Escrow Agent will
           then prepare and deliver to Depositor and Preferred Beneficiary a
           report describing the information so identified. It shall be the
           responsibility of the Depositor, and not Escrow Agent, to ensure that
           the Deposit Materials contain the information so identified in Escrow
           Agent's report, as well as any other information that may be required
           in the License Agreement.

        b. Preferred Beneficiary shall have the right to cause a verification of
           any Deposit Materials, at Preferred Beneficiary's expense (except
           Depositor shall pay such cost if the verification fails). Preferred
           Beneficiary shall notify Depositor and Escrow Agent of Preferred
           Beneficiary's request for verification. Depositor shall have the right
           to be present at the verification. If a verification is elected after
           the Deposit Materials have been delivered to Escrow Agent, then only
           Escrow Agent, or at Escrow Agent's election an independent person or
           company selected and supervised by Escrow Agent, may perform the
           verification.

1.7 Deposit Updates.

        a. Generally. Unless otherwise provided by the License Agreement,
           Depositor shall update the Deposit Materials within thirty (30) days
           of each release of a new version of the product, which is subject to
           the License Agreement. Such updates will be added to the existing
           deposit. All deposit updates shall be listed on a new Exhibit 2 and
           Depositor shall sign the new Exhibit 2. Each Exhibit 2 will be held
           and maintained separately within the escrow account. An independent
           record will be created which will document the activity for each
           Exhibit 2. The processing of all deposit updates shall be in
           accordance with Sections 1.2 through 1.6 above. All references in this
           Agreement to the Deposit Materials shall include the initial Deposit
           Materials and any updates.

        b. DeposiTrack Service. Escrow Agent shall notify Depositor in writing
           semi-annually of Depositor's obligation to make updated deposits.
           Within thirty (30) days of receipt of such notice, Depositor shall
           certify in writing to Escrow Agent that (a) it has made the updated
           deposits as required in the immediately preceding paragraph; or (b)
           there has not been a release of a new version of the product since the
           last deposit. After the thirty (30) days, Escrow Agent shall notify
           Preferred Beneficiary that Escrow Agent has received (a) an updated
           deposit from Depositor; (b) a statement from Depositor advising there
           has not been a release of a new version of the product since the last
           deposit; or (c) no response from Depositor.

1.8 Removal of Deposit Materials. The Deposit Materials may be removed and/or
    exchanged only on written instructions signed by Depositor and Preferred
    Beneficiary, or as otherwise provided in this Agreement.

                                       54

                                    ARTICLE 2
                       CONFIDENTIALITY AND RECORD KEEPING

2.1 Confidentiality. Escrow Agent shall maintain the Deposit Materials in a
    secure, environmentally safe, locked facility, which is accessible only to
    authorized representatives of Escrow Agent. Escrow Agent shall have the
    obligation to reasonably protect the confidentiality of the Deposit
    Materials. Except as provided in this Agreement, Escrow Agent shall not
    disclose, transfer, make available, or use the Deposit Materials. Escrow
    Agent shall not disclose the content of this Agreement to any third party.
    If Escrow Agent receives a subpoena or any other order from a court or
    other judicial tribunal pertaining to the disclosure or release of the
    Deposit Materials, Escrow Agent will immediately notify the parties to this
    Agreement unless prohibited by law. It shall be the responsibility of
    Depositor and/or Preferred Beneficiary to challenge any such order;
    provided, however, that Escrow Agent does not waive its rights to present
    its position with respect to any such order. Escrow Agent will not be
    required to disobey any order from a court or other judicial tribunal. (See
    Section 7.5 below for notices of requested orders.)

2.2 Audit Rights. During the term of this Agreement, Depositor and Preferred
    Beneficiary shall each have the right to inspect the written records of
    Escrow Agent pertaining to this Agreement. Any inspection shall be held
    during normal business hours and following reasonable prior notice.

                                    ARTICLE 3
                         GRANT OF RIGHTS TO Escrow Agent

3.1 Title to Media. Depositor hereby transfers to Escrow Agent the title to the
    media upon which the proprietary technology and materials are written or
    stored. However, this transfer does not include the ownership of the
    proprietary technology and materials contained on the media such as any
    copyright, trade secret, patent or other intellectual property rights.

3.2 Right to Make Copies. Escrow Agent shall have the right to make copies of
    the Deposit Materials as reasonably necessary to perform this Agreement.
    Escrow Agent shall copy all copyright, nondisclosure, and other proprietary
    notices and titles contained on the Deposit Materials onto any copies made
    by Escrow Agent. With all Deposit Materials submitted to Escrow Agent,
    Depositor shall provide any and all instructions as may be necessary to
    duplicate the Deposit Materials including but not limited to the hardware
    and/or software needed.

3.3 Right to Transfer Upon Release. Depositor hereby grants to Escrow Agent the
    right to transfer Deposit Materials to Preferred Beneficiary in accordance
    with Section 4.5. Except upon such a release or as otherwise provided in
    this Agreement, Escrow Agent shall not transfer the Deposit Materials.

                                       55

                                    ARTICLE 4
                               RELEASE OF DEPOSIT

4.1 Release Conditions. As used in this Agreement, "Release Conditions" shall
    mean the existence of any one or more of the following circumstances,
    uncorrected for more than thirty (30) days:

        a. Depositor's failure to carry out material obligations imposed on it
           pursuant to the License Agreement;

        b. Entry of an order for relief for Depositor under Title 11 of the
           United States Code;

        c. The making by Depositor of a general assignment for the benefit of
           creditors;

        d. The appointment of a general receiver or trustee in bankruptcy of
           Depositor's business or property;

        e. Action by Depositor under any state insolvency or similar law for the
           purpose of its bankruptcy, reorganization or liquidation; or

        f. Depositor's failure to continue to do business in the ordinary course.

4.2 Filing for Release. If Preferred Beneficiary believes in good faith that a
    Release Condition has occurred, Preferred Beneficiary may provide to Escrow
    Agent written notice of the occurrence of the Release Condition and a
    request for the release of the Deposit Materials. Upon receipt of such
    notice, Escrow Agent shall provide a copy of the notice to Depositor by
    commercial express mail.

4.3 Contrary Instructions. From the date Escrow Agent mails the notice
    requesting release of the Deposit Materials, Depositor shall have ten (10)
    business days to deliver to Escrow Agent contrary instructions ("Contrary
    Instructions"). Contrary Instructions shall mean the written representation
    by Depositor that a Release Condition has not occurred or has been cured.
    Upon receipt of Contrary Instructions, Escrow Agent shall send a copy to
    Preferred Beneficiary by commercial express mail. Additionally, Escrow
    Agent shall notify both Depositor and Preferred Beneficiary that there is a
    dispute to be resolved pursuant to Section 7.3 of this Agreement. Escrow
    Agent will continue to store the Deposit Materials without release pending
    (a) joint instructions from Depositor and Preferred Beneficiary; (b)
    dispute resolution pursuant to Section 7.3; or (c) order of a court.

4.4 Release of Deposit. If Escrow Agent does not receive Contrary Instructions
    from the Depositor, Escrow Agent is authorized to release the Deposit
    Materials to the Preferred Beneficiary or, if more than one beneficiary is
    registered to the deposit, to release a copy of the Deposit Materials to
    the Preferred Beneficiary. However, Escrow Agent is entitled to receive any
    fees due Escrow Agent before making the release. Any copying expense in
    excess of $300 will be chargeable to Preferred Beneficiary. Upon any such

                                       56

    release, the escrow arrangement will terminate as it relates to the
    Depositor and Preferred Beneficiary involved in the release.

4.5 Right to Use Following Release. Unless otherwise provided in the License
    Agreement, upon release of the Deposit Materials in accordance with this
    Article 4, Preferred Beneficiary shall have the right to use the Deposit
    Materials for the sole purpose of continuing the benefits afforded to
    Preferred Beneficiary by the License Agreement. Preferred Beneficiary shall
    be obligated to maintain the confidentiality of the released Deposit
    Materials.

                                   ARTICLE 5
                              TERM AND TERMINATION

5.1 Term of Agreement. The initial term of this Agreement is for a period of
    one year. Thereafter, this Agreement shall automatically renew from
    year-to-year unless (a) Depositor and Preferred Beneficiary jointly
    instruct Escrow Agent in writing that the Agreement is terminated; or (b)
    Escrow Agent instructs Depositor and Preferred Beneficiary in writing that
    the Agreement is terminated for nonpayment in accordance with Section 5.2
    or by resignation in accordance with Section 5.3. If the Acceptance Form
    has been signed at a date later than this Agreement, the initial term of
    the Acceptance Form will be for one year with subsequent terms to be
    adjusted to match the anniversary date of this Agreement. If the Deposit
    Materials are subject to another escrow agreement with Escrow Agent, Escrow
    Agent reserves the right, after the initial one year term, to adjust the
    anniversary date of this Agreement to match the then prevailing anniversary
    date of such other escrow arrangements.

5.2 Termination for Nonpayment. In the event of the nonpayment of fees owed to
    Escrow Agent, Escrow Agent shall provide written notice of delinquency to
    the parties to this Agreement affected by such delinquency. Any such party
    shall have the right to make the payment to Escrow Agent to cure the
    default. If the past due payment is not received in full by Escrow Agent
    within one month of the date of such notice, then at any time thereafter
    Escrow Agent shall have the right to terminate this Agreement to the extent
    it relates to the delinquent party by sending written notice of termination
    to such affected parties. Escrow Agent shall have no obligation to take any
    action under this Agreement so long as any payment due to Escrow Agent
    remains unpaid.

5.3 Termination By Resignation. Escrow Agent reserves the right to terminate
    this Agreement, for any reason, by providing Depositor and Preferred
    Beneficiary with 60-days' written notice of its intent to terminate this
    Agreement. Within the 60-day period, the Depositor and Preferred
    Beneficiary may provide Escrow Agent with joint written instructions
    authorizing Escrow Agent to forward the Deposit Materials to another escrow
    company and/or agent or other designated recipient. If Escrow Agent does
    not receive said joint written instructions within 60 days of the date of
    Escrow Agent's written termination notice, then Escrow Agent shall destroy,
    return or otherwise deliver the Deposit Materials in accordance with
    Section 5.4.

                                       57

5.4 Disposition of Deposit Materials Upon Termination. Subject to the foregoing
    termination provisions, and upon termination of this Agreement, Escrow
    Agent shall destroy, return, or otherwise deliver the Deposit Materials in
    accordance with instructions. If there are no instructions, Escrow Agent
    may, at its sole discretion, destroy the Deposit Materials or return them
    to Depositor. Escrow Agent shall have no obligation to destroy or return
    the Deposit Materials if the Deposit Materials are subject to another
    escrow agreement with Escrow Agent or have been released to the Preferred
    Beneficiary in accordance with Section 4.4.

5.5 Survival of Terms Following Termination. Upon termination of this
    Agreement, the following provisions of this Agreement shall survive:

        a. Depositor's Representations (Section 1.5);

        b. The obligations of confidentiality with respect to the Deposit
           Materials;

        c. The rights granted in the sections entitled Right to Transfer Upon
           Release (Section 3.3) and Right to Use Following Release (Section
           4.5), if a release of the Deposit Materials has occurred prior to
           termination;

        d. The obligation to pay Escrow Agent any fees and expenses due;

        e. The provisions of Article7; and

        f. Any provisions in this Agreement, which specifically state they
           survive the termination of this Agreement.

                                    ARTICLE 6
                               ESCROW AGENT'S FEES

6.1 Fee Schedule. Escrow Agent is entitled to be paid its standard fees and
    expenses applicable to the services provided. Unless otherwise stated in
    this Agreement or agreed in a writing signed by Escrow Agent, Preferred
    Beneficiary will pay Escrow Agent's fees. Escrow Agent shall notify the
    party responsible for payment of Escrow Agent's fees at least sixty (60)
    days prior to any increase in fees. For any service not listed on Escrow
    Agent's standard fee schedule, Escrow Agent will provide a quote prior to
    rendering the service, if requested.

6.2 Payment Terms. Escrow Agent shall not be required to perform any service
    unless the payment for such service and any outstanding balances owed to
    Escrow Agent are paid in full. Fees are due upon receipt of a signed
    contract or receipt of the Deposit Materials whichever is earliest. If
    invoiced fees are not paid, Escrow Agent may terminate this Agreement in
    accordance with Section 5.2.

                                       58

                                    ARTICLE 7
                             LIABILITY AND DISPUTES

7.1 Right to Rely on Instructions. Escrow Agent may act in reliance upon any
    instruction, instrument, or signature reasonably believed by Escrow Agent
    to be genuine. Escrow Agent may assume that any employee of a party to this
    Agreement who gives any written notice, request, or instruction has the
    authority to do so. Escrow Agent shall not be required to inquire into the
    truth or evaluate the merit of any statement or representation contained in
    any notice or document. Escrow Agent shall not be responsible for failure
    to act as a result of causes beyond the reasonable control of Escrow Agent.

7.2 Indemnification. Depositor and Preferred Beneficiary each agree to
    indemnify, defend and hold harmless Escrow Agent from any and all claims,
    actions, damages, arbitration fees and expenses, costs, attorney's fees and
    other liabilities ("Liabilities") incurred by Escrow Agent relating in any
    way to this escrow arrangement unless such Liabilities were caused solely
    by the negligence or willful misconduct of Escrow Agent.

7.3 Dispute Resolution. Any dispute relating to or arising from this Agreement
    shall be resolved by arbitration using a panel of three (3) arbitrators
    under the Commercial Rules of the American Arbitration Association. Three
    arbitrators shall be selected. The Depositor and Preferred Beneficiary
    shall each select one arbitrator and the two chosen arbitrators shall
    select the third arbitrator, or failing agreement on the selection of the
    third arbitrator, the American Arbitration Association shall select the
    third arbitrator. However, if Escrow Agent is a party to the arbitration,
    Escrow Agent shall select the third arbitrator. Unless otherwise agreed by
    Depositor and Preferred Beneficiary, arbitration will take place in
    Atlanta, Georgia, USA. Any court having jurisdiction over the matter may
    enter judgment on the award of the arbitrators. Service of a petition to
    confirm the arbitration award may be made by First Class mail or by
    commercial express mail, to the attorney for the party or, if
    unrepresented, to the party at the last known business address.

7.4 Controlling Law. This Agreement is to be governed and construed in
    accordance with the laws of Georgia, without regard to its conflict of law
    provisions.

7.5 Notice of Requested Order. If any party intends to obtain an order from the
    arbitrator or any court of competent jurisdiction, which may direct Escrow
    Agent to take, or refrain from taking any action, that party shall:

        a. Give Escrow Agent at least two business days' prior notice of the hearing;

        b. Include in any such order that, as a precondition to Escrow Agent's
           obligation, Escrow Agent be paid in full for any past due fees and be
           paid for the reasonable value of the services to be rendered pursuant
           to such order; and

                                       59

        c. Ensure that Escrow Agent not be required to deliver the original (as
           opposed to a copy) of the Deposit Materials if Escrow Agent may need
           to retain the original in its possession to fulfill any of its other
           escrow duties.

                                    ARTICLE 8
                               GENERAL PROVISIONS

8.1 Entire Agreement. This Agreement, which includes the Acceptance Form and
    Exhibits described herein, embodies the entire understanding among all of
    the parties with respect to its subject matter and supersedes all previous
    communications, representations or understandings, either oral or written.
    Escrow Agent is not a party to the License Agreement between Depositor and
    Preferred Beneficiary and has no knowledge of any of the terms or
    provisions of any such License Agreement. Escrow Agent's only obligations
    to Depositor or Preferred Beneficiary are as set forth in this Agreement.
    No amendment or modification of this Agreement shall be valid or binding
    unless signed by all the parties hereto, except that Exhibit 1 need not be
    signed by Escrow Agent, Exhibit 2 need not be signed by Preferred
    Beneficiary, and the Acceptance Form need only be signed by the parties
    identified therein.

8.2 Notices. All notices, invoices, payments, deposits and other documents and
    communications shall be given to the parties at the addresses specified
    from time to time. It shall be the responsibility of the parties to notify
    each other as provided in this Section in the event of a change of address.
    The parties shall have the right to rely on the last known address of the
    other parties. Unless otherwise provided in this Agreement, all documents
    and communications may be delivered by First Class mail.

8.3 Severability. In the event any provision of this Agreement is found to be
    invalid, voidable or unenforceable, the parties agree that unless it
    materially affects the entire intent and purpose of this Agreement, such
    invalidity, voidability or unenforceability shall affect neither the
    validity of this Agreement nor the remaining provisions herein, and the
    provision in question shall be deemed to be replaced with a valid and
    enforceable provision most closely reflecting the intent and purpose of the
    original provision.

8.4 Successors. This Agreement shall be binding upon and shall inure to the
    benefit of the successors and assigns of the parties. However, Escrow Agent
    shall have no obligation in performing this Agreement to recognize any
    successor or assign of Depositor or Preferred Beneficiary unless Escrow
    Agent receives clear, authoritative and conclusive written evidence of the
    change of parties.

8.5 Regulations. Depositor and Preferred Beneficiary are responsible for and
    warrant compliance with all applicable laws, rules and regulations,
    including but not limited to customs laws, import, export, and re-export
    laws and government regulations of any country from or to which the Deposit
    Materials may be delivered in accordance with the provisions of this
    Agreement.

                                       60

IN WITNESS WHEREOF AND INTENDING TO BE BOUND, the parties hereto execute this
Agreement through their authorized representatives as of the date first above
written.

INNERSPACE CORPORATION

By:/s/Robert D. Arkin
   Robert D. Arkin
   Chief Executive Officer

THE KRC GROUP, INC.

By:/s/Robert Crowe
   Robert Crowe
   Chief Executive Officer

RAIFORD & DIXON, LLP

By:/s/A. Todd Merolla
   A. Todd Merolla, Esq.
   Partner

                                       61

                                    EXHIBIT 1
                            MATERIALS TO BE DEPOSITED

Depositor represents to Preferred Beneficiary that Deposit Materials delivered
to Escrow Agent shall consist of the following:

 Signature: ________________________
 Print Name: _______________________
 Date: _____________________________

                                       62

                                    EXHIBIT 2
                        DESCRIPTION OF DEPOSIT MATERIALS

 Product Name: ____________________________ Version: _____________

DEPOSIT MATERIAL DESCRIPTION:
 Quantity Media Type & Size Label Description of Each Separate Item

 ____ Disk3.5" or ____
 ____ DAT tape ____mm
 ____ CD-ROM
 ____ Data cartridge tape ____
 ____ TK70 or ____ tape
 ____ Magnetic tape ____
 ____ Documentation
 ____ Other ______________________

 PRODUCT DESCRIPTION:
 Environment: ______________________________________________________________

 DEPOSIT MATERIAL INFORMATION:
Is the media or are any of the files encrypted? Yes / No If yes, please include
any passwords and the decryption tools.
Encryption tool name________________________ Version:__________________

Hardware required: _________________________________________________________
Software required: _________________________________________________________
Other required information: ________________________________________________

I certify for Depositor that the above described Deposit Materials have been
transmitted to Escrow Agent:

Signature: ________________________
Print Name: _______________________
Date: _____________________________

Escrow Agent has inspected and accepted the above materials (any exceptions are
noted above):

Signature: _________________________
Print Name: ________________________
Date Accepted:______________________
Exhibit 2#:_________________________

                                       63

                                    EXHIBIT F
                       SOFTWARE MAINTENANCE SUPPORT POLICY

The KRC Group, Inc. will provide support services for the Licensed Program as
follows:

1. 24X7 telephone support by qualified personnel designated by The KRC Group,
   Inc. to assure the performance described in Exhibit B.

2. This level of support will be provided and remain in effect for the term of
   the License Agreement (since the License Fees described at Section 3.1 of
   the License Agreement include maintenance and support fees).

3. Support services include without limitation the following:

        a. Technical services to remedy software application defects.

        b. Technical support for hardware, communications or other equipment The
           KRC Group, Inc. specifically provides in order for the Licensed
           Program to perform in accordance with Exhibit B.

4. Support services are directly provided to employees, agents, affiliates and
   officers of InnerSpace Corporation, including Health Unified, Inc. Support
   services are not directly provided to end users.

On-site support will be provided at an additional fee of $150.00 / hour as well
as ordinary and customary out of pocket expenses including pre-approved
transportation expenses.

                                       64synermedicsconsultingagmt

        THIS LICENSE AGREEMENT is made as of the 28th day of February, 2002 between
Synermedics, Inc., a corporation organized and existing under the laws of the
State of Georgia ("Licensor"), and InnerSpace Corporation, a corporation
organized and existing under the laws of the State of Delaware ("Licensee").

        The Effective Date is February 28, 2002.

        WHEREAS Licensor owns the Licensed Program and Licensed Technical
Information (each as defined below) and copyrights and other proprietary rights
relating thereto; and

        WHEREAS, subject to the terms, conditions and provisions hereinafter set
forth, Licensee desires to obtain from Licensor, and Licensor desires to grant
to Licensee a nonexclusive, fully paid-up license to (i) use the Licensed
Program and Licensed Technical Information on a worldwide basis and (ii) use and
modify source code of the Licensed Program;

        NOW, THERFORE in consideration of the premises and of the promises and
mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, and intending to be
legally bound hereby, the parties hereto agree as follows:

                                    ARTICLE 1
                                   DEFINITIONS

        The following terms, as used herein, shall have the following meanings:

        "AFFILIATE" means, when used with references to Licensee, any Person
directly or indirectly controlling, controlled by or under common control with
Licensee. For purposes of this Agreement, 'control' means the direct or indirect
ownership of over 50% of the outstanding voting securities of a Person, or the
right to receive over 50% of the profits or earnings of a Person, or the right
to control the policy decisions of a Person.

        "CONFIDENTIAL INFORMATION" means and includes (i) the source code and
object code of the Licensed Program and the related Documentation, (ii) the
Licensed Technical Information; and (iii) any other written or oral information
from which the furnishing party derives economic value, actual or potential,
from such information not being generally known to, and not being readily
ascertainable by proper means by, other persons who can obtain economic value
from its disclosure or use, and which is the subject of efforts that are
reasonable under the circumstances to maintain its secrecy.

        "COPYRIGHT" means the copyrights related to the Licensed Work, including
the copyright applications and registration(s), if any, listed on Exhibit A
attached hereto and made part hereof, authorized under Title 17 of the United
States Code or under the laws of any other jurisdiction.

        "CUSTOMER" means any Person who has executed a valid End User Agreement or
any other form of sublicense agreement relating to the license set forth herein.

                                       1

        "DOCUMENTATION" means the explanatory and instructive materials in
hardcopy, including manuals and other printed or visually perceptible materials
that describe the use, function or operation of a computer software program.

        "END USER AGREEMENT" means an agreement between Licensee and a Person
granting the right to use or benefit from any of the rights granted hereinunder.

        "LICENSE FEES" shall mean the payments made by Licensee to Licensor hereunder.

        "LICENSED PROGRAM" means the software program in source code, object code,
or any other form having the copyright registrations and applications for
copyright registration set forth in Exhibit A hereto and the specifications and
functionality described in Exhibit B hereto, together with (i) Modifications
thereto, (ii) all Documentation, and (iii) all derivative works based on the
foregoing.

        "LICENSED TECHNICAL INFORMATION" means data furnished by Licensor that is
used to populate the database component of the Licensed Program.

        "LICENSED WORK" means the Licensed Program, the Licensed Technical
Information and any derivative works, as well as all United States and foreign
Copyrights.

        "MODIFICATION" of work means any and all changes including improvements,
enhancements, corrections, revisions to the work or any portion thereof, and any
derivative of or work substantially similar to any of the foregoing, made by
Licensor or the Licensee.

        "PERSON" or "PERSONS" means any corporation, partnership, joint venture or
natural person.

        "PROVIDER" means a natural person, licensed as a physician, a nurse
practitioner or other medical professional, that provides healthcare services to
patients on a regularly scheduled basis and bills those patients for his or her
professional services. For purposes hereof, the term, "Provider" does not mean a
nurse or other allied health professional who assists the Provider in the
delivery of healthcare services to patients but who does not bill those patients
for his or her professional services.

        "SALE" as applied to the Licensed Work means a genuine bonafide transaction
for which consideration is received or expected for the use, lease, transfer or
any other disposition of the Licensed Work. A Sale of the Licensed Work shall be
deemed completed at the time Licensee or its sublicensee receives payment for
such Licensed Work.

                                       2

                                    ARTICLE 2
                                GRANT OF LICENSE

2.1 GRANT OF LICENSE. Subject to the terms and conditions contained in this
    Agreement, Licensor hereby grants to Licensee for the term of this
    Agreement a fully paid up, perpetual, worldwide, nonexclusive license, with
    a right to sublicense to:

        (a) Host and use the Licensed Work;

        (b) make copies of, and make derivative works of, the Licensed Work, for
            the use of Licensee in accordance with the terms of this Agreement
            including, without limitation, the confidentiality provisions
            contained herein;

        (c) distribute the Licensed Work in object code only;

        (d) sublicense the Licensed Work in object code only to customers of
            Licensee who have first executed an End User Agreement in a form that
            is reasonably acceptable to Licensor;

        (e) market the Licensed Work on a private label basis,

        (f) use and make Modifications to the source code of the Licensed Program.

2.2 RESERVATION OF RIGHTS. Licensor reserves the right to make copies of, to
    make derivative works of and to use the Licensed Work for commercial
    purposes and to license the Licensed Work to third parties subject to the
    terms of this Agreement.

2.3 NO RIGHTS BY IMPLICATION. No rights or licenses with respect to the
    Licensee Work are granted or deemed granted hereunder or in connection
    herewith, other than those rights or licenses expressly granted in this
    Agreement.

                                   ARTICLE 3
                                    PAYMENTS

3.1 PAYMENTS. In consideration for the license granted by this Agreement,
    Licensee shall pay Licensor as follows:

        (a) 1,800,000 shares of Licensee's common stock, deliverable upon
            execution of this Agreement;

        (b) $50,000, payable not later than July 31, 2002.

3.2 ROYALITES. The obligation of Licensee to pay the Fees and Net Service
    Bureau Access Fees described at Section 3.1 of that certain License
    Agreement between Licensor and Licensee dated as of February 28, 2001, or
    any other license fees or minimum royalties, is hereby terminated and of no
    further force and effect. The terms, "Fees" and "Net Service Bureau Access
    Fees" have the meaning ascribed in said Agreement.

3.3 CURRENCY, PLACE OF PAYMENT. All dollar amounts referred to in this
    Agreement are expressed in United States dollars. All payments other
    amounts to Licensor under this Agreement shall be made in United States
    dollars in immediately available funds.

                                       3

                                   ARTICLE 4
               HOSTING, TRAINING, SUPPORT AND MAINTENANCE SERVICES

4.1 HOSTING. Licensee and its agents will assume all responsibility for hosting
    the Licensed Work for the benefit of its Customers. Licensor will be under
    no obligation to host the Licensed Work for the benefit of Licensee or
    Licensee's Customers.

4.2 TRAINING AND IMPLEMENTATION. Licensor will provide remote technical
    assistance and consultation to Licensee with respect to use of the Licensed
    Work at a rate of the lesser of $800 per day or $150 per hour (billed in
    increments of 15 minutes).

4.3 MAINTENANCE. Licensor will correct defects and provide Licensee with fixes
    to the Licensed Work. Any assistance required to fulfill Licensor's
    obligations under this Section will be provided at no additional charge
    unless such assistance is found to be the result of hardware failure, user
    error, neglect or negligence. Assistance required as a result of such
    failure, user error, neglect or negligence will be compensated by the
    Licensee at the rate of $150 per hour (billed in increments of 15 minutes).

4.4 UPGRADES. Licensor has no obligation to support the Licensed Work to assure
    that it remains commercially viable and satisfies applicable regulatory and
    health industry standards. However, Licensor will provide Licensee with any
    and all upgrades it makes to the Licensed Work at no additional charge.

4.5 ACCESS TO LICENSED WORK. Licensee shall provide Licensor with remote access
    to the installed Licensed Work and its affiliated hardware during regular
    business hours, and for reasonable periods of time, for the purpose of
    testing, identification of defects, and installation of any changes, fix or
    upgrade. Licensor will exercise best efforts to coordinate with Licensee an
    appropriate schedule to perform service and support so as to minimize the
    operational impact to Licensee's operations. In appropriate circumstances,
    at the sole discretion of Licensor, changes, fixes or upgrades may be
    delivered through appropriate magnetic media, electronically transmitted or
    delivered through a representative of Licensor.

4.6 EXCUSED PERFORMANCE. Licensor shall not be liable for any failure to
    perform or delayed performance of any obligation under the Agreement if
    such performance is prevented, hindered or delayed by reason of any cause
    beyond the reasonable control of Licensor, including, without limitation,
    any labor dispute, strike or other industrial disturbance, act of God,
    flood, shortage of materials from various manufacturers, earthquakes,
    hurricanes, casualty, war, act of public enemy, riot, insurrection, embargo
    law, blockage, action, restriction and regulation or order of any
    government, government agency or subdivision thereof.

                                    ARTICLE 5
                                    WARRANTY

5.1 WARRANTY. THE LICENSED WORK IS PROVIDED ON AN "AS IS" BASIS AND LICENSOR
    MAKES NO REPRESENTATIONS OR WARRANTEES, EXPRESS OR IMPLIED, WITH RESPECT

                                       4

    THERETO. BY WAY OF EXAMPLE BUT NOT OF LIMITATION, THE LICENSOR MAKES NO
    REPRESENTATIONS OR WARRANTEES (i) OF COMMERCIAL UTILITY, (ii) OF
    MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR (iii) THAT THE USE
    OF THE LICENSED WORK WILL NOT INFRINGE ANY PATENT, COPYRIGHT OR TRADEMARK
    OR OTHER PROPRIETARY OR PROPERTY RIGHTS OF OTHERS. EXCEPT AS EXPRESSLY
    PROVIDED HEREIN, LICENSOR DISCLAIMS ANY WARRANTY THAT THE LICENSED WORK IS
    FREE FROM THE RIGHTFUL CLAIMS OF ANY THIRD PARTY. LICENSOR SHALL NOT BE
    LIABLE TO LICENSEE, LICENSEE"S SUCCESSORS OR ASSIGNS, OR ANY OTHER THIRD
    PARTY WITH RESPECT TO ANY CLAIM ON ACCOUNT OF, OR ARISING FROM THE USE OF
    INFORMATION IN CONNECTION WITH THE LICENSED WORK SUPPLIED HEREUNDER OR THE
    USE OR LICENSE OF THE LICENSED WORK OR ANY OTHER MATERIAL OR ITEM DERIVED
    THEREFROM. LICENSOR SHALL NOT BE LIABLE TO LICENSEE, OR ANY OTHER PERSON
    FOR ANY LOSS OF PROFITS, LOSS OF BUSINESS OR INTERRUPTION OF BUSINESS, OR
    FOR ANY INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES OF ANY KIND INCURRED BY
    LICENSEE OR ANY OTHER PERSON WHETHER UNDER THIS AGREEMENT OR OTHERWISE,
    EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSS.

5.2 LICENSEE INDEMNIFICATION. Licensee will indemnify and hold harmless
    Licensor, its, officers, agents and employees (collectively, the
    "Indemnified Parties"), from and against any and all liability, loss,
    damage, action, claim or expense suffered or incurred by the Indemnified
    Parties (including reasonable attorney's fees) (individually, a "Liability"
    and collectively, the "Liabilities") which results from or arises out of
    (a) the use of the Licensed Work by Licensee, its Affiliates, assignees,
    vendors or other third parties; (b) breach by Licensee of any covenant or
    agreement contained in this Agreement; and (c) the successful enforcement
    by an indemnified Party of its right under this Section. The
    indemnification obligation under clause (a) shall be mitigated by the sole
    negligence of the Indemnified Party. Without limiting the foregoing,
    Licensee will indemnify and hold harmless the Indemnified Parties from and
    against any Liabilities resulting from: (a) Any claim of any kind related
    to the use by a third party of the Licensed Work by Licensee, its
    Affiliates, assignees, or other third parties; and (b) any claim by a third
    party that the Licensed work infringes or violates any patent, copyright,
    trademark or other intellectual property rights of such third party.

5.3 PROCEDURES. The Indemnified Party shall promptly notify Licensee of any
    claim or action giving rise to a Liability that is subject to the
    provisions of this Article. Licensee shall have the right to defend any
    such claim or action, at its cost and expense. Licensee shall not settle or
    compromise any such claim or action in a manner that imposes any
    restrictions or obligations on Licensor or grants any rights to the
    Licensed Work, without Licensor's written consent, which consent shall not
    be unreasonably withheld. If Licensee fails or declines to assume the
    defense of any such claim or action within thirty (30) days after notice
    thereof, Licensor may assume the defense of such claim or action for the
    account and at the risk of Licensee, and any Liability related thereto
    shall be conclusively deemed a liability of Licensee. Licensee shall pay
    promptly to the Indemnified Party any Liabilities to which the foregoing
    indemnify relates, as incurred. The indemnification rights of Licensor or

                                       5

    other indemnified Party contained herein are in addition to all other
    rights which such indemnified Party may have at law or in equity or
    otherwise.

                                   ARTICLE 6
                         MODIFICATION OF LICENSED WORK.

6.1 MODIFICATIONS.

        (a) Licensee shall have the right to make Modifications of the Licensed
            Work, including derivatives, which Modifications, and all patents,
            copyrights and trademarks relating thereto, shall become the property
            of Licensee from the moment of their creation, subject to the
            Licensor's license rights hereunder.

        (b) Licensee may from time to time release Modifications developed by
            Licensor, subject to the Licensee's license rights hereunder. Licensor
            will provide one copy of such Modifications to Licensee.
            Notwithstanding, Licensee acknowledges and agrees that the Licensor
            shall have no obligation to make Modifications of the Licensed Work.

                                   ARTICLE 7
                                 CONFIDENTIALITY

7.1 NONDISCLOSURE.

        (a) Licensee shall maintain in confidence and shall not disclose to any
            third Party (except an authorized sublicensee) the Confidential
            Information received pursuant to this Agreement, without the prior
            written consent of Licensor. The foregoing obligation shall not apply
            to: (i) information that is known to Licensee or independently
            developed by Licensee prior to the time of disclosure; (ii)
            information disclosed to Licensee by a third party that has a right to
            make such disclosure; (iii) information that becomes patented,
            published or otherwise part of the public domain as a result of acts
            by Licensor or by a third person who has the right to make such
            disclosure; or (iv) information that is required to be disclosed by
            order of any governmental authority or a court of competent
            jurisdiction; provided that Licensee shall notify Licensor if it
            believes such disclosure is required and shall use its best efforts to
            obtain confidential treatment of such information by the agency or
            court.

        (b) Licensor shall maintain in confidence and shall not disclose to any
            third Party (except an authorized sublicensee) the Confidential
            Information received pursuant to this Agreement, without the prior
            written consent of Licensee. The foregoing obligation shall not apply
            to: (i) information that is known to Licensor or independently
            developed by Licensor prior to the time of disclosure; (ii)
            information disclosed to Licensor by a third party that has a right to
            make such disclosure; (iii) information that becomes patented,
            published or otherwise part of the public domain as a result of acts
            by Licensee or by a third person who has the right to make such
            disclosure; or (iv) information that is required to be disclosed by

                                       6

            order of any governmental authority or a court of competent
            jurisdiction; provided that Licensor shall notify Licensee if it
            believes such disclosure is required and shall use its best efforts to
            obtain confidential treatment of such information by the agency or
            court.

        (c) The receiving party's obligations of confidentiality with respect to
            Confidential Information that constitute trade secrets under the
            Uniform Trade Secrets Act as adopted in the State of Georgia (or other
            similar applicable law) shall run for as long as such information
            remains a trade secret. The receiving party's obligations of
            confidentiality with respect to Confidential Information that is not
            covered under the Uniform Trade Secrets Act as adopted in the State of
            Georgia (or other similar applicable law), shall run for three (3)
            years from the date of termination of this Agreement.

7.2 USE OF CONFIDENTIAL INFORMATION.

        (a) Licensee shall ensure that all of its employees, agents and
            contractors having access to the Confidential Information of Licensor
            are obligated in writing to abide by Licensee's obligations hereunder.
            Licensee shall use the Confidential Information only for the purposes
            contemplated under this Agreement.

        (b) Licensor shall ensure that all of its employees, agents and
            contractors having access to the Confidential Information of Licensee
            are obligated in writing to abide by Licensor's obligations hereunder.
            Licensor shall use the Confidential Information only for the purposes
            contemplated under this Agreement.

7.3 INJUNCTIVE RELIEF. Because damages at law will be an inadequate remedy for
    breach of any of the covenants, promises and agreements contained in this
    Article 6 hereof, the aggrieved party shall be entitled to injunctive
    relief in any state or federal court located within the City of Atlanta,
    Georgia, including specific performance or an order enjoining the breaching
    party from any threatened or actual breach of such covenants, promises or
    agreements. The rights set forth in this Section shall be in addition to
    any other rights which the aggrieved party may have at law or in equity.

                                   ARTICLE 8
                         WARRANTIES AND REPRESENTATIONS

8.1 REPRESENTATIONS AND WARRANTIES OF LICENSOR. Licensor represents and
    warrants to Licensee that

        (a) Licensor is a corporation duly organized, validly existing and in good
            standing under the laws of Georgia, and has all requisite corporate
            power and authority to execute, deliver and perform this Agreement.

        (b) This Agreement, when executed and delivered by Licensor, will be the
            legal, valid and binding obligation of Licensor, enforceable against
            Licensor in accordance with its terms.

                                       7

        (c) The execution, delivery and performance of this Agreement by Licensor
            does not conflict with, or constitute a breach or default under, (i)
            the charter documents of Licensor, (ii) any law, order, judgment or
            governmental rule or regulation applicable to Licensor, or (iii) any
            provision of any agreement, contract, commitment or instrument to
            which Licensor is a party; and the execution, delivery and performance
            of this Agreement by Licensor does not require the consent, approval
            or authorization of, or notice or declaration to or filing or
            registration with, any governmental or regulatory authority.

        (d) Licensor holds full right, title and interest in and to the Licensed
            Work. To its knowledge, the Licensed Work does not infringe the
            proprietary rights of any third party. Licensor has not received any
            written notice that the Licensed Work infringes the proprietary rights
            of any third party.

8.2 REPRESENTATIONS AND WARRANTIES OF LICENSEE. Licensee represents and
    warrants to Licensor that

        (a) Licensee is a corporation duly organized, validly existing and in good
            standing under the laws of Delaware, and has all requisite corporate
            power and authority to execute, deliver and perform this Agreement.

        (b) This Agreement, when executed and delivered by Licensee, will be the
            legal, valid and binding obligation of Licensee, enforceable against
            Licensee in accordance with its terms.

        (c) The execution, delivery and performance of this Agreement by Licensee
            does not conflict with, or constitute a breach or default under, (i)
            the charter documents of Licensee, (ii) any law, order, judgment or
            governmental rule or regulation applicable to Licensee, or (iii) any
            provision of any agreement, contract, commitment or instrument to
            which Licensee is a party; and the execution, delivery and performance
            of this Agreement by Licensee does not require the consent, approval
            or authorization of, or notice or declaration to or filing or
            registration with, any governmental or regulatory authority.

                                   ARTICLE 9
                       PROPRIERARY RIGHTS AND INFRINGEMENT

9.1 RIGHTS PROTECTION.

        (a) LICENSEE CONTROL. Licensee shall be responsible for and shall control
            the preparation, prosecution and maintenance of all copyrights and
            patent rights pertaining to the Licensed Work.

        (b) LICENSOR PROSECUTION. If Licensee elects not to file, prosecute or
            maintain any copyright or patent to the Licensed Work, it shall notify
            Licensor at least sixty (60) days prior to taking, or not taking, any
            action which would result in abandonment, withdrawal, or lapse of such
            right. Licensor shall then have the right to file, prosecute or
            maintain the right at its own expense and set off such expense from
            the royalty payments due Licensor hereinunder.

                                       8

        (c) COOPERATION. Each party shall cooperate with the other party to
            execute all lawful papers and instruments and to make all rightful
            oaths and declarations as may be necessary in the preparation and
            prosecution of all rights referred to in this Section.

9.2 INTELLECTUAL PROPERTY INFRINGEMENT CLAIMS; INFRINGEMENT BY THIRD PARTY.

        (a) THIRD PARTY INFRINGEMENT.

                (i) LICENSEE'S OBLIGATIONS. Each party will promptly notify the other
                    party of any infringement or possible infringement of rights
                    relating to the Licensed Work by a third-party. Licensee shall
                    have the right, but not the obligation, to prosecute such
                    infringement at its own expense. In such event, Licensor shall
                    cooperate with Licensee, at Licensee's expense. Licensee shall
                    not settle or compromise any such suit in a manner that imposes
                    any obligations or restrictions on Licensor or grants any rights
                    to the Licensed Work, without Licensor's written consent.

               (ii) LICENSOR'S RIGHTS. If Licensee fails to prosecute such
                    infringement within ninety (90) days after receiving notice
                    thereof, Licensor shall have the right, but not the obligation,
                    to prosecute such infringement at its own expense. In such event,
                    Licensee shall cooperate with Licensor, at Licensor's expense.

               (iii)RECOVERY DISTRIBUTION. Any recovery obtained by the prosecuting
                    party as a result of such proceeding, by settlement or otherwise,
                    shall be applied first to the prosecuting party, in an amount
                    equal to its costs and expenses of the litigation, with the
                    remainder to be paid to the Licensee, subject to the earned
                    PAYMENTS due to Licensor under Article 3 hereof.

                                   ARTICLE 10
                              TERM AND TERMINATION

10.1 TERM. This Agreement and the licenses granted herein shall commence on the
     Effective Date and shall continue, subject to earlier termination under
     Sections 11.2 or 11.3 hereof, in perpetuity or, if a specified term is
     required by law, for a period of thirty (30) years thereafter.

10.2 TERMINATION BY LICENSOR.

        (a) EVENTS OF DEFAULT. Upon the occurrence of any of the events set forth
            below ("Events of Default"), Licensor shall have the right to
            terminate this Agreement by giving written notice of termination, such
            termination being effective with the giving of such notice:

                                       9

                (i) Nonpayment of any amount payable to Licensor that is continuing
                    then (10) calendar days after Licensor gives Licensee written
                    notice of such nonpayment;

                (ii) breach by Licensee of any covenant (other than a payment breach
                     referred to in clause (i) above) or any representation or
                     warranty contained in this Agreement that is continuing sixty
                     (60) calendar days after Licensor gives Licensee written notice
                     of such breach; provided that if Licensee, using its best
                     efforts, cannot cure such breach within the flat sixty (60) days,
                     the cure period shall be extended by an additional sixty (60)
                     calendar days, the total cure period not to exceed one hundred
                     twenty (120) days; or

                (iii)Licensee fails to comply with the terms of the license granted
                     under Article 2 hereof and such noncompliance is continuing
                     thirty (30) calendar days after Licensor gives Licensee notice of
                     such noncompliance;

10.3 NO WAIVER. No exercise by Licensor of any right of termination shall
     constitute a waiver of any right of Licensor for recovery of any monies
     then due to it hereunder or any other right or remedy Licensor may have at
     law or under this Agreement.

10.4 RIGHTS AND DUTIES UPON TERMINATION. Within thirty (30) days after
     termination of this Agreement, each party shall return to the other party
     any Confidential Information of the other Party. Licensee also shall return
     all copies of the Licensed Program in its possession that are embodied in
     physical form to Licensor promptly upon the termination of this Agreement.

10.5 SUBLICENSES. Any sublicenses granted by Licensee under this Agreement and
     conforming substantially to the form of End User License Agreement agreed
     to by the parties shall survive termination of this Agreement in accordance
     with the terms of such sublicense.

10.6 PROVISIONS SURVIVING TERMINATION. Licensee's obligation to make payments
     accrued but unpaid prior to termination of this Agreement shall survive
     such termination. In addition, any other provisions required to interpret
     the rights and obligations of the parties arising prior to the termination
     date shall survive expiration or termination of this Agreement.

                                   ARTICLE 11
                              ADDITIONAL PROVISIONS

11.1 ASSIGNMENT. This Agreement may be assigned by either party upon written
     notice to the nonassigning party. No assignment shall relieve Licensee of
     responsibility for the performance of any obligations which have accrued
     prior to such assignment.

11.2 NO WAIVER. A waiver by either party of a breach or violation of any
     provision of this Agreement must be in writing in order to be effective. No
     waiver will constitute or be construed as a waiver of any subsequent breach
     or violation of that provision or as a waiver of any breach or violation of
     any other provision of this Agreement.

                                       10

11.3 INDEPENDENT CONTRACTOR. Nothing herein shall be deemed to establish a
     relationship of principal and agent between Licensor and Licensee, nor any
     of their agents or employees for any purpose whatsoever. This Agreement
     shall not be construed as constituting Licensor and Licensee as partners,
     or as creating any other form of legal association or arrangement that
     could impose liability upon one party for the act or failure to act of the
     other party.

11.4 NOTICES. Any notice under this Agreement shall be sufficiently given if
     sent in writing by prepaid, first class, certified or registered mail,
     return receipt requested, addressed as follows:

        (a) If to Licensor, to

                  Synermedics, Inc.
                  860 Denison Street
                  Unit 7
                  Markham, Ontario  L3R 4H1
                  Canada

        (b) If to Licensee, to:

                  InnerSpace Corporation
                  201 Allen Road NE
                  Suite 310
                  Atlanta, Georgia  30328-4864

                  or to such other addresses as may be designated from time to time
                  by notice given in accordance with the terms of this Section.

11.5 ENTIRE AGREEMENT. This Agreement embodies the entire understanding between
     the parties relating to the subject matter hereof and supersedes all prior
     understandings and agreements, whether written or oral. This Agreement may
     not be varied except by a written document signed by duly authorized
     representatives of both parties.

11.6 SEVERABILITY. Any of the provisions of this Agreement which are determined
     to be invalid or unenforceable in any jurisdiction shall be ineffective to
     the extent of such invalidity or unenforceability in such jurisdiction,
     without rendering invalid or unenforceable the remaining provisions hereof
     or affecting the validity or unenforceability of any of the terms of this
     Agreement in any other jurisdiction.

11.7 HEADINGS. Any headings and captions used in this Agreement are for
     convenience of reference only and shall not affect its construction or
     interpretation.

                                       11

11.8 NO THIRD PARTY BENEFITS. Nothing in this Agreement, express or implied, is
     intended to confer on any person other than the parties hereto or their
     permitted assigns, any benefits, rights or remedies.

11.9 GOVERNING LAW. This Agreement shall be construed, governed, interpreted and
     applied in accordance with the laws of the State of Georgia, without giving
     effect to conflict of law provisions.

11.10 COUNTERPARTS. This Agreement shall become binding when any one or more
      counterparts hereof, individually or taken together, shall bear the
      signatures of each of the parties hereto. This Agreement may be executed in
      any number of counterparts, each of which shall be deemed an original as
      against the party whose signature appears thereon, but all of which
      together shall constitute but one and the same instrument.

11.11 FURTHER ASSURANCES. The parties shall sign such other instruments, cause
      such meetings to be held and resolutions passed, exercise their vote and
      influence, do and perform and cause to be done and performed such further
      and other acts as things as may be reasonably necessary or desirable to
      give full effect to the intent and purposes of this Agreement.

                                       12

IN WITNESS WHEREOF AND INTENDING TO BE BOUND, the parties hereto execute this
Agreement through their authorized representatives as of the date first above
written.

INNERSPACE CORPORATION

By:/s/Robert D. Arkin
   Robert D. Arkin
   Chief Executive Officer

SYNERMEDICS, INC.

By:/s/Jay Stulberg
   Jay Stulberg
   President

                                       13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00041-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00041-of-00352.parquet"}]]